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Arginine uptake and degradation systems are common throughout bacteria and
archaea.  The genome of human pathogen Chlamydia pneumoniae encodes three proteins
now called AaxA, AaxB, and AaxC which function together to take up arginine,
decarboxylate it, and expel the decarboxylation product, agmatine.  AaxB is the
previously characterized pyruvoyl-dependent arginine decarboxylase, AaxC is an inner
membrane amino acid transport protein that functions as an arginine-agmatine antiporter,
and AaxA is an outer membrane porin, which facilitates the uptake of arginine and also
functions as a general porin with broad specificity.  C. pneumoniae is a non-typical Gram
negative bacteria and an obligate intracellular parasite with a unique 2-phase life cycle.
The role of this system for arginine-agmatine exchange has yet to be determined but it
may function to deplete host cell arginine as a means of inactivating host inducible nitric
oxide synthase (iNOS), a molecule used in the innate immune response that has been
vii
shown to have an inhibitory affect on the growth of C. pneumoniae in cell culture.  AaxB
and AaxC are able to complement the loss of extreme acid-resistance in E. coli mutants
that lack their own system for arginine-agmatine exchange, making pH homeostasis
another possible role for this system.  The porin AaxA is able to enhance arginine-
agmatine exchange by AaxB and AaxC in E. coli mutants as well as by the native
arginine decarboxylase AdiA and the native arginine-agmatine antiporter AdiC in wild
type E. coli.  AaxA is not an arginine-specific porin and instead acts as a general porin
with a broad specificity.  AaxA discriminates only against large and negatively charged
solute molecules, and therefore it may have a broad role in the uptake of various
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AaxA, AaxB, and AaxC from Chlamydia pneumoniae comprise a system for
arginine uptake and decarboxylation as well as agmatine export.  AaxA is an outer
membrane porin that allows arginine and agmatine, as well as other solutes, to diffuse
freely across the outer membrane.  AaxC is an arginine-agmatine antiporter that
transports arginine into the cell across the cytoplasmic membrane while transporting
agmatine, the decarboxylation product of arginine, out of the cell.  AaxB is the arginine
decarboxylase that converts arginine to agmatine (Figure 1.1).  There are many possible
roles for such a system in bacteria but its role in C. pneumoniae remains to be proved.
One possibility that will be considered in this dissertation is that the Aax system
consumes arginine for the purpose of inhibiting host nitric oxide synthesis as a means of
resisting the innate immune system.
The work on this system began with the C. pneumoniae protein now called AaxB,
a pyruvoyl-dependent arginine decarboxylase encoded by the gene Cpn1032 (Giles and
Graham, 2007).  This gene is flanked upstream by Cpn1033 and downstream by
Cpn1031.  These genes were predicted to encode an outer membrane porin and a
cytoplasmic membrane transporter protein, respectively.  It was hypothesized that this
transporter could be an arginine-agmatine antiporter.  The pairing of an arginine
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decarboxylase with an arginine-agmatine antiporter is found in enteric bacteria although
no such system was known in chlamydial species.  The putative outer membrane porin
has no homolog in enteric bacteria but it was hypothesized that it could facilitate arginine
uptake into the cell.
The focus of this dissertation is the characterization of the protein encoded by
Cpn1031, now known to be the arginine-agmatine antiporter AaxC, and the protein
encoded by Cpn1033, now known to be the general porin AaxA.  This introduction will
provide an overview of arginine uptake and degradation systems in other bacteria,
bacterial porins, arginine-agmatine exchange in bacteria, the arginine decarboxylase from
C. pneumoniae, the chlamydial life cycle and the organism’s role in human disease, as
well as C. pneumoniae’s relationship with nitric oxide during infection.
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Figure 1.1.  Aax proteins comprise a system for arginine-agmatine exchange.
The outer membrane porin AaxA allows both arginine and agmatine to diffuse freely
across the outer membrane.  AaxC exchanges extracellular arginine for intracellular
agmatine across the cytoplasmic membrane.  AaxB is the arginine decarboxylase, which
converts arginine to agmatine.
1.1. THE CHLAMYDIAL LIFE CYCLE
Chlamydiae are aerobic Gram-negative bacterial pathogens that exist as obligate
intracellular parasites with a unique two phase life cycle.   The infectious form is the
elementary body (EB), which enters the host cells through receptor-mediated
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the host cytoskeleton is rearranged to aid in redistribution of EB-containing vacuoles to
the perinuclear region.  The vacuoles can fuse with each other but they do not fuse with
lysosomes.  Homotypic endosomal fusion, in which multiple chlamydial inclusions are
able to fuse together, occurs only in C. trachomatis and provides an opportunity for
genetic exchange not found in other species which present in multiple inclusions per
infected cell, consistent with multiplicity of infection (Wyrick, 2000).
EBs (0.25-0.30 µm) are considered metabolically inert and they must differentiate
into the non-infectious but metabolically active reticulate bodies (RBs) (0.8-1.0 µm) to
reproduce.  RBs, unlike the smaller and hardier EBs, are osmotically unstable and will
lyse outside of the host cell.  Logarithmic growth begins roughly 6 hours post infection
and continues until 24 to 40 hours post infection, depending on the species, with a
generation time of about 2.5 hours.  RBs grow entirely within the inclusion vacuole
created by the EBs’ entry into the host cell and this vacuole expands as the RBs grow in
number, intercepting vesicles released from the trans-golgi.  Active RBs group around the
periphery of the growing inclusion vacuole, presumably to take nutrients from the host,
but as they fully mature and differentiate back into EBs, which are not metabolically
active, they cluster in the center.  RBs that adhere to the inclusion membrane may draw
their nutrients from the cytoplasm using hollow structural appendages called projections,
which originate in the cytoplasmic membrane and extend about 30 nm from the
chlamydial surface.  These projections may also be involved in secreting molecules into
the host cell cytoplasm to modulate host-parasite interactions (Wyrick, 2000).
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After differentiating back to EBs these infectious bodies must leave the protective
inclusion vacuole to escape and infect other cells.  Exit may occur by lysis or vacuolar
fusion with the cytoplasmic membrane and results in the cycle of infection,
differentiation, and growth starting over again from the beginning.  Any cells that have
not successfully differentiated back into EBs will lyse outside the host cell.
Chlamydia can only reproduce by invading the host cell, partially because of the
osmotically unstable nature of their vegetative form and partially because of their
fastidious nutrient requirements.  Chlamydiae encode enzymes for the glycolytic
pathway, the pentose phosphate pathway, the Embden-Meyerhof-Parnas pathway, and a
partial TCA cycle as well as components of a functional electron transport chain (Wyrick,
2000).  Chlamydia must take many nutrients from its host including glucose-6-phosphate,
2-oxoglutarate, succinate, oxaloacetate, amino acids, nucleotides, and other essential
molecules that chlamydial species cannot produce themselves (McClarty, 1999).
1.2. CHLAMYDIAL DISSEASE
Chlamydial bacteria are responsible for a wide variety of diseases in humans
including conjunctivitis, cervicitis, urethritis, and pneumonia.  C. trachomatis causes
genital infection as well as trachoma, which can lead to blindness.  C. pneumoniae causes
10% of pneumonia cases and 5% of bronchitis and sinusitis cases annually (Kuo et al.
1995).  Roughly 50% of the population presents detectable levels of antibody against C.
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pneumoniae by age 20 and about 75% of the elderly population show detectable levels of
antibody (Kuo et al., 1995).  Although most cases of chlamydial infection can be resolved
with antibiotics such as azithromycin or doxycycline, asymptomatic infection can make
diagnosis difficult and C. pneumoniae and C. trachomatis can both persist to cause
chronic infections that are resistant to standard treatments (Turner et al., 2002,
Workowski et al. 2006).  There is currently no effective vaccine against chlamydia.
Illness caused by C. pneumoniae most frequently manifests as bronchitis or
pneumonia but asymptomatic or mildly symptomatic infections are most common (Kuo
et al., 1995).  Pneumonia caused by C. pneumoniae is usually mild, not requiring
hospitalization, but recovery is often very slow with symptoms lingering for weeks.
Older patients tend to suffer more severe symptoms than young adults and in cases of
underlying illness and complications such as pneumococcal bacteremia fatalities can
result.  Severe systemic infections can occur, although they are uncommon.  Other
diseases associated with C. pneumoniae include sinusitis, otitis media, pharyngitis,
endocarditis, and lumbosacral meningoradiculitis.  C. pneumoniae has also been shown to
have a roll in the development or exacerbation of asthma (Kuo et al., 1995, Hahn et al.,
2006).
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1.3. ARGININE UPTAKE AND DEGRADATION
Arginine uptake and degradation systems are common in many bacteria and
archaea, and they are used for a variety of purposes ranging from ATP formation to
defense against the innate immune system.  Pseudomonas aeruginosa uses the membrane
protein ArcD to import arginine, which is converted to ornithine by the arginine
deiminase pathway (Verhoogt et al., 1992).  The degradation of arginine is carried out in
this case by the arginine deiminase ArcA, which catalyzes the conversion of arginine to
citrulline and ammonia, the ornithine carbamoyl transferase ArcB, which produces
ornithine and carbamoyl phosphate, and the carbamate kinase ArcC that converts ADP to
ATP and produces CO2 and ammonia.  ArcD exports the ornithine produced by this
process.  Chlamydiae have no homolog for the arginine deiminase gene and there is no
evidence that they are able to ferment arginine.
Many bacteria and archaea use arginine decarboxylases to produce agmatine,
which is then converted by agmatine ureohydrolase to putrescine (Giles and Graham,
2008, Graham et al., 2002).  Putrescine is the core polyamine used in the synthesis of
spermidine and spermine.  Polyamines are important regulators of cell growth and
differentiation as well as cell death and they are ubiquitous in bacteria, archaea, and
eukaryotes.  However, the agmatine ureohydrolase enzyme is lacking in chlamydia
species, ruling out this pathway for arginine catabolism as well.
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Arginine decarboxylases need not be tied to polyamine biosynthesis; in many
enteric bacteria, including Escherichia coli and Salmonella enterica, a pyridoxal 5’-
phosphate (PLP) dependent arginine decarboxylase enzyme (AdiA) is coupled with an
arginine-agmatine antiporter (AdiC) as part of a system for acid resistance and survival
(Gong et al., 2003, Iyer et al., 2003, Fang et al., 2006, Kieboom and Abee, 2006).  This
system acts as a virtual proton pump and serves to raise the cytoplasmic pH while
inverting the cell’s membrane potential, creating an internal positive charge to repel
protons and enhancing the rate of survival for these bacteria in the low pH environment
of the stomach before they are able to colonize the gut (Richard and Foster, 2004, Fang et
al., 2009).  The chlamydial pyruvoyl-dependent arginine decarboxylase AaxB together
with the arginine agmatine Antiporter AaxC could serve in a similar fashion, but there is
no evidence of acidification during chlamydial infections, making this role unlikely
(Fields and Hackstadt, 2002).
Arginine is converted to nitric oxide (NO) and citrulline by inducible nitric oxide
synthase (iNOS) in macrophages.  NO is an effective antimicrobial agent and is an
important component of innate immunity.  Helicobacter pylori uses an arginase (RocF) to
hydrolyze arginine to urea and ornithine, a reaction that has been shown to consume host
cell arginine and reduce the amount of NO released by macrophages (Gobert et al.,
2001).  Chlamydia pneumoniae infects granulocytes and alveolar macrophages in early
stage acute respiratory infections, both of which use arginine to produce nitric oxide,
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suggesting that C. pneumoniae, like H. pylori, may use its system for arginine uptake and
degradation to protect itself from NO-mediated killing (Giles and Graham, 2009).
1.4. BACTERIAL PORINS
Outer membranes in Gram-negative bacteria are composed of an outer leaflet of
lipopolysaccharide (LPS) and an inner leaflet of conventional lipids like
phosphatidylethanolamine (Jap and Walian, 1996).  The outer membrane is made
permeable to hydrophilic solutes by the presence of channel-forming proteins called
porins.  The transport of solute through these porins is driven by diffusion and does not
require energy from the cell.  The number and type of porins in the outer membrane
determine the permeability of the membrane to different kinds of solutes and can be
adjusted in response to changes in the bacterial cell’s environment.  A porin’s solute
preference is determined by the size and geometry of the pore as well as the distribution
of charged, polar, and aromatic amino acids.  Additionally, some porins contain binding
sites for specific substrates that give the porin greater specificity.  It is the presence or
absence of these binding sites that differentiates specific porins from general porins.
Porins are composed primarily of cylinders of β-sheets and are often made up of 3
monomers, each serving as a distinct channel.  E. coli OmpA and P. aeruginosa OprF are
examples of porins, which function in the membrane as monomers.  Usually the porin
cylinders are made up of 16 β-strands of varying lengths, although LamB from E. coli
has 18 β-strands per cylinder.  Overall topology as well as the general distribution of
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hydrophobic and hydrophilic residues in bacterial porins is very similar from species to
species even though sequence similarity is generally very low.  The central region is
made up of a belt of nonpolar residues about 25 Ångstroms in height with a ring of
aromatic amino acids at the top and at the bottom positioned so that their polar portions
interact with the polar headgroups of the lipids making up the membrane bilayer while
the aromatic rings interact with the hydrophobic core (Jap and Walian, 1996).  Inside the
porin channel itself negatively charged residues are positioned across from positively
charged residues in a pattern that rotates along the length of the channel.  The porin
channel has wide external and internal openings but constricts in the middle of the
channel, creating an hourglass geometry.  The specifics of these structures determines the
size exclusion limits of the porin as well as the preferences for solutes, which are
determined largely by the distribution of charged resides within the channel and the
presence or absence of substrate binding sites (Jap and Walian, 1996).
In chlamydial species the major outer membrane protein (MOMP) and the
dicarboxylate-specific porin PorB have already been characterized (Jones, et al., 2000,
Sun et al., 2007, Kubo and Stephens, 2001).  MOMP is a general porin with size
selectivity for molecules less than 200 M. W. when expressed in E. coli (Jones et al.
2000).  This contrasts with the general porins in E. coli, which have a size exclusion limit
of 600 M. W. (Jap and Walian, 1996).  PorB is present in chlamydial outer membranes at
much lower amounts than MOMP and is specific in allowing only the uptake of 2-
oxoglutarate and a few other dicarboxylates.  AaxA is the newest chlamydial outer
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membrane porin to be characterized and its further study will expand our understanding
of the outer membrane dynamics of chlamydial bacteria (Smith and Graham, 2008).
1.5. ARGININE-AGMATINE EXCHANGE
Antiporters are transport proteins that transport substrates across the cytoplasmic
membrane by coupling transport of one molecule into the cytoplasm to that of another out
of the cell.  The AdiC protein in E. coli is an amino acid transport protein localized to the
cytoplasmic membrane which functions as an arginine-agmatine antiporter (Gong et al,
2003, Iyer et al., 2003, Fang et al., 2006).  Together with the PLP-dependent arginine
decarboxylase AdiA this antiporter allows for the exchange of extracellular arginine for
the arginine decarboxylation product agmatine.  The purpose of this exchange is to
elevate the internal pH of the cell by using up aqueous protons with the decarboxylation
of arginine and in the process to reverse the cell’s membrane potential, allowing E. coli to
survive the low pH environment of the stomach on the way to colonizing the gut.  AdiC
exists as a homodimer in phospholipid membranes with each subunit functioning as a
transporter (Fang et al., 2009).  The expression of AdiA and AdiC is induced under
anaerbobic, acidic conditions and the AdiAC system for arginine agmatine exchange is
most active at pH 2.5, showing only minimal activity above pH 3 (Gong et al., 2003).
The adiY gene is located between adiA and adiC but, although over expression of AdiY
reportedly increased adiA transcription, deletion of adiY was shown to have no effect on
arginine-dependent acid resistance, suggesting that it may serve as a conditional regulator
(Gong et al., 2003).
12
1.6. THE CHLAMYDIAL ARGININE DECARBOXYLASE
Arginine decarboxylation is carried out in C. pneumoniae by AaxB.  The
decarboxylation reaction is shown in the following equation:
R-COO- + H+ → R-H + CO2
While most arginine decarboxylases require pyridoxal 5’-phosphate (PLP) as a co-
factor for activity, some enzymes, including AaxB, use a covalently attached pyruvoyl
group.  This co-factor acts as the prosthetic group for the formation of a Schiff’s base
with the arginine substrate while providing an electron sink to stabilize the negatively
charged intermediate (Graham et al., 2002).  Pyruvoyl-dependent arginine decarboxylases
are translated as autocatalytic pro-enzymes that self-cleave to yield the small amino-
terminal β fragment and the large carboxyl-terminal α fragment.   Methanocaldococcus
jannaschii uses such an arginine decarboxylase, and so does Chlamydia pneumoniae
(Graham et al., 2002, Giles and Graham, 2007).  These enzymes have the advantage of a
co-factor that is covalently bound to the enzyme, eliminating competition with other
enzymes for available PLP.
The pyruvoyl-dependent arginine decarboxylase from C. pneumoniae, now called
AaxB, was discovered as a homolog for the arginine decarboxylase from M. jannaschii, a
kind of archaea that lives in hydrothermal vents and uses its arginine decarboxylase in
polyamine biosynthesis (Graham et al., 2002).  CPn1032 (AaxB) was heterologously
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expressed and purified in E. coli and it was found to self-cleave to give an active enzyme
with an optimum activity at pH 3.4 (Giles and Graham 2007).
The arginine decarboxylases in Chlamydia trachomatis strains L2 and D, unlike
AaxB in C. pneumoniae, were found to be inactive when expressed in E. coli (Giles and
Graham, 2009).  AaxB in the C. trachomatis L2 strain contains a nonsense mutation,
which could be rescued by replacing the ochre stop codon with its ancestral tryptophan
codon while AaxB from the D strain expressed as a proenzyme defective for self-
cleavage that could be rescued by replacing the arginine-115 codon with an ancestral
glycine codon (Giles and Graham 2009).  These results suggest a relaxed selection for the
maintenance of AaxB in C. trachomatis compared with C. pneumoniae, which may be a
factor in tissue tropism, given that C. trachomatis generally infects mucosal epithelial
cells, which do not express inducible nitric oxide synthase (iNOS), while C. pneumoniae
infects granulocytes and alveolar macrophages, which do express iNOS (Giles and
Graham, 2009).
1.7.  C. PNEUMONIAE AND NITRIC OXIDE
As previously mentioned, arginine uptake and degradation can be used as a means
of countering the production of antimicrobial nitric oxide (NO) by macrophages, as in the
case of H. pylori (Gobert et al., 2001).  It is possible that C. pneumoniae, which can
infect granulocytes and alveolar macrophages, may use its arginine-agmatine exchange
system for this purpose as well.   Additionally, agmatine, the product of arginine
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decarboxylation by AaxB, has been shown to suppress the generation of NO by inducible
nitric oxide synthase (iNOS) in cell culture after being converted to an aldehyde product
by host diamine oxidase (Satriano et al., 2001).  The coupling of arginine degradation
with the production of an iNOS inhibitor could make the chlamydial AAX system even
more effective.  It has already been reported that C. trachomatis strains, which do not
generally infect cell types that express inducible nitric oxide synthase, have shown
progressive inactivation of the genes for arginine-agmatine exchange by independent
mutations (Giles and Graham, 2009).
It has been demonstrated that NO production stimulated by the addition of IFN-γ
results in the inhibition of C. pneumoniae growth in macrophages but adding the nitric
oxide synthase (NOS) inhibitor N-monomethyl-L-arginine (L-NMMA) restored growth
(Carratelli et al., 2005).  A similar trend was observed with the exogenous addition of an
NO donor.  These results showed that NO has a role in combating infection by C.
pneumoniae and that inhibition of NOS can enhance its ability to infect and reproduce in
host cells.   It should be noted that the arginine concentration in the cell culture medium
used for these tests was 1.1 mM while the extracellular arginine concentration in the lung
is only 73-150 µM (Dweik, 2007).  Therefore, it is possible that the arginine uptake and
degradation system in C. pneumoniae was unable to significantly affect NO production
due to the excessive amounts of arginine present in the media.  Additional experiments
using physiologically relevant concentrations of arginine will be needed to determine if
NO-mediated inhibition of C. pneumoniae growth can be reduced by the AAX system.
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CHAPTER 2
Arginine uptake by AaxC
2.1. OVERVIEW
AaxC was hypothesized to be the chlamydial arginine-agmatine antiporter that
would work together with AaxB to create a system for arginine-agmatine exchange.  The
gene Cpn1031 was designated as aaxC after its role in arginine-agmatine exchange was
established.  AaxC’s arginine-agmatine exchange function is driven by the chlamydial
arginine decarboxylase AaxB (Cpn1032), a protein that was previously characterized in
our lab.  Cpn1033, now designated aaxA encodes the outer membrane porin AaxA, which
will be detailed in later chapters.  These 3 genes have been identified in all sequenced
chlamydial genomes although functional proteins are not expressed in all strains (Giles
and Graham, 2007, Giles and Graham, 2009, Smith and Graham, 2008).
AaxC and AaxB were predicted to have activity analogous to that of AdiC and AdiA
from E. coli.  AdiC is the E. coli arginine-agmatine antiporter and AdiA is the E. coli
arginine decarboxylase and together with the regulatory protein AdiY they function as a
system for acid-resistance (Gong et al, 2003, Iyer et al., 2003, Fang et al., 2006). AdiC is
a member of the major facilitator superfamily (MFS) of transport proteins.  By taking up
Arg+ and exporting Agm+2 AdiC acts as a virtual proton pump.   AdiA drives this
exchange by decarboxylating the imported arginine, consuming protons and elevating the
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intracellular pH as agmatine, with its virtual proton, is removed from the cell by AdiC.
Thus, E. coli cells are able to survive the acidic environment in the stomach on their way
to colonize the gut.  Although chlamydial bacteria do not encounter this environment
during their own pathogenic life cycle the ability of the Aax proteins to function as an
acid resistance system when expressed in E. coli was investigated (Smith and Graham,
2008).
To determine if AaxC shared the same function as AdiC, aaxC and aaxBC from
Chlamydia pneumoniae were expressed from plasmids in E. coli mutants unable to
express adiAYC.  Cell membranes were separated by sucrose-density gradient
centrifugation and western blot analysis was used to determine that AaxC was localized
to the cytoplasmic membrane, as would be predicted if AaxC shares a function with E.
coli AdiC, which also localizes to the cytoplasmic membrane.  Uptake assays using L-
[3H]arginine were used to measure AaxC’s ability to import arginine into the cell.  In the
absence of any arginine decarboxylase, AaxC was observed to mediate the exchange of
radiolabeled extracellular arginine for unlabeled intracellular arginine.  Although
arginine-agmatine exchange driven by the AaxB arginine decarboxylase was much more
efficient, as detailed in chapter 3, these uptake assays verified AaxC’s role in taking
extracellular arginine into the cell.  Together with the localization of AaxC to the
cytoplasmic membrane, these results confirmed that AaxC is at least somewhat analogous
to AdiC.  Because AaxB is an arginine decarboxylase, identical to AdiA in function
though not in mechanism, it was predicted that AaxBC would be able to rescue acid
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resistance function in E. coli cells unable to express AdiAYC  (Smith and Graham,
2007).
To address the question of whether AaxC could function together with AaxB to
allow acid-resistance in E. coli cells defective for their native arginine-agmatine
exchange system, a complementation assay was used.  Cells were subjected to acid shock
in media adjusted to pH 2.5 for 1 hour in the presence or absence of arginine.  Cells
expressing AaxBC in the presence of arginine were able to survive at wild type levels
while negative controls without AaxBC showed minimal survival after the same
treatment.  Without arginine in the media all cells showed minimal survival (Smith and
Graham, 2007).
Because C. pneumoniae is not known to encounter such low pH environments
during normal pathogenesis, the ability of the aax genes to complement E. coli cells
defective for adiAYC is interesting but may not be directly relevant to the chlamydial life
cycle.  C. pneumoniae does not pass through the gastrointestinal tract during infection
and therefore does not need to cope with the acidic environment found in the stomach, an
obstacle that enteric bacteria like E. coli must overcome.  Additionally, while chlamydial
bacterial are taken up by host cells and grow within an inclusion vacuole, this vacuole
does not fuse with acidifying lysosomes (Scidmore et al., 2003).  Furthermore, while
AaxB was shown to have a low optimum pH of 3.4, AaxC-mediated arginine uptake was
most efficient from pH 5 to 6.  AaxA, which has no equivalent in enteric bacteria, has an
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even higher optimum pH, as will be detailed in chapter 4.  Finally, the Aax system
evolved independently of the Adi system found in E. coli.  AaxB is a pyruvoyl-dependent
arginine decarboxylase while AdiA is uses PLP as a cofactor.  AaxB is more closely
related to the poylamine-biosynthetic arginine decarboxylase found in euryarchaea
(Graham et al., 2002).  AaxC is more closely related to ArcD, the arginine-ornithine
antiporter found in Pseudomonas aeruginosa than it is to the E. coli arginine-agmatine
antiporter AdiC (Verhoogt et al., 1992, Gong et al., 2003).  While it may be possible that
C. pneumoniae must endure low pH environments under some currently unknown
circumstances during its life cycle, it is more likely that it uses its system for arginine-
agmatine exchange in another way (Smith and Graham, 2007).
2.2. EXPERIMENTAL PROCEDURES
2.2.1. Strains and DNA
C. pneumoniae Kajaani 6 chromosomal DNA was a gift from Claudio Cortes
Miranda and Benjamin Wizel (University of Texas Health Center at Tyler) (Ekman et al.,
1993). E. coli EF1021 was a gift from John Foster (University of South Alabama) (Gong
et al., 2003). E. coli MG1655 (CGSC 7740) was obtained from the E. coli Genetic Stock
Center (Yale). E. coli DH5α (Invitrogen) was used as a general cloning host.
Bacteriophage P1vir was a gift from Ian Molineux (University of Texas at Austin).
19
2.2.2. Cloning
The multiple cloning site of vector pBAD/HisA was amplified by PCR using
primers pBADMCS2 and pBAD-Rev.  The purified product was digested with NcoI and
HindIII restriction enzymes and then ligated into the same sites of pBAD/HisA to
produce vector pDG219. Primers 5CPn1031N and 3CPn1031H were used to amplify the
CPn1031 gene from C. pneumoniae K6 chromosomal DNA. The PCR product was
ligated between NdeI and HindIII sites in vector pET-43.1b to produce vector pDG133.
Primers 5CPn1031Nc and 3CPn1031H2 were used to amplify CPn1031 from pDG133.
The product was ligated between NcoI and HindIII sites of pBAD/HisA to produce
pDG170 and between the same sites of pTrcHisA to produce pDG183. Primers
5CPn1031Nc and COLIDOWN-RI were used to amplify the CPn1031-HSV cassette
from pDG133. The cassette encodes the CPn1031 protein fused to a carboxy-terminal
herpes simplex virus (HSV) glycoprotein D epitope sequence (Novagen). This cassette
was ligated between the NcoI and EcoRI sites of pTrcHisA to produce vector pDG193
and between the same sites of pBAD/HisA to produce vector pDG194. Primers
5CPn1032Nc and 3CPn1031H were used to amplify the CPn1032 and CPn1031 gene
pair. This PCR product was digested with NcoI and HindIII and ligated into the same
sites of plasmid pET-43.1b to produce plasmid pDG360 and in plasmid pBAD/HisA to
produce pDG379. The CPn1032-CPn1031-HSV cassette was amplified from pDG360
using the primers 5CPn1032Nc and COLIDOWN. This product was digested with NcoI,
phosphorylated with polynucleotide kinase, and ligated between the NcoI and SmaI sites
of pDG219 to produce vector pDG366 (Smith and Graham, 2008).
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See the Appendix for a table detailing strain information.
 Two plasmids containing E. coli membrane proteins were constructed to provide
markers for chlamydial membrane protein localization. LepA (EF4) is a 67-kDa
cytoplasmic membrane-associated ribosomal back translocase (March et al., 1985, Qin et
al., 2006). The lepA gene with its upstream sequence was amplified from E. coli DNA by
using the primers 5lepAH and 3lepAX. The restriction-digested PCR product was ligated
to the HindIII and XhoI sites of vector pCDFDuet-1 to produce plasmid pDG561. This
multicopy plasmid encodes the LepA sequence fused to a carboxy-terminal S-Tag
sequence (Novagen), under the control of the native lepA promoter. OmpX is an 18-kDa
outer membrane protein that is overexpressed during chemical stress conditions (Dupont,
et al., 2007). The ompX gene with its upstream sequence was amplified from E. coli DNA
using the primers 5ompXH and 3ompXX. The product was ligated to the HindIII and
XhoI sites of the multicopy vector pCOLADuet-1 to produce plasmid pDG552. The
pDG552 plasmid encodes the native OmpX fused to a carboxy-terminal S-Tag sequence.
Both the pDG561 and the pDG552 plasmids were transformed into E. coli BW25113 to
create a marker strain. In addition, the pDG552 plasmid was transformed into E. coli
BL21(DE3) to express ompX from a T7 RNA polymerase promoter (Smith and Graham,
2008).
An adiAYC deletion mutation was generated by the gene disruption method of
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Datsenko and Wanner (Datsenko et al., 2000). The adiC1::kan allele from E. coli strain
EF1021 was transduced into strain MG1655 using bacteriophage P1vir, producing strain
DEG0100. DEG0100 cells were transformed with vector pCP20, and grown under
nonpermissive conditions for plasmid replication (37°C). The kanamycin-sensitive (Kans)
recombinant strain DEG0124 was screened by PCR using the primers EcadiCUP and
EcadiCDOWN, confirming the excision of the FLP-kan cassette. Primers EcAdiAFwd1
and EcAdiARev1 were used to amplify the kanamycin resistance cassette from pKD13
(Datsenko et al., 2000). E. coli DEG0124(pKD46) was transformed with the resulting
adiA1::kan PCR product. Recombinant strains were selected by growth on LB agar
containing kanamycin (25 mg ml–1). The adiAYC::kan allele in a Kanr recombinant
(DEG0147) was confirmed by PCR using the primers EcadiAFwd2 and EcadiCDOWN.
The purified 1.6-kbp PCR product was sequenced, confirming the deletion (Smith and
Graham, 2008).
2.2.3. Protein Expression
Expression vectors were transformed into E. coli strains by electroporation. E.
coli strains carrying pBAD/HisA or derivative plasmids were grown aerobically at 37°C
for 22 h in LB Miller medium supplemented with ampicillin (100 µg ml–1) and L-
arabinose (0.15% [wt/vol]). For protein expression analysis by Western blotting, cells
were grown with L-arabinose for 6 h to reduce proteolytic cleavage. E. coli strains
carrying pET-43.1a or pTrcHisA derivative plasmids were grown with ampicillin and
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induced with 1 mM IPTG (isopropyl-ß-D-thiogalactopyranoside) (Smith and Graham,
2008).
2.2.4. Membrane fractionation by sucrose-density gradient centrifugation
E. coli cells were lysed by sonication, and the lysates were cleared of debris by
low-speed centrifugation. Membranes were prepared by ultracentrifugation of these
samples at 100,000 x g for 1 h at 4°C in a Beckman TLA-100.3 rotor (Ward et al., 2000).
For total membrane protein analysis, the pellets were resuspended in 2% SDS with 20
mM Tris-HCl (pH 7.5). Suspensions were centrifuged at 100,000 x g for 1 h at 4°C. The
supernatant was concentrated by using a centrifugal ultrafiltration device (10,000
molecular weight cutoff; Pall Life Sciences). For fractionation by sucrose-density
gradient centrifugation, the membrane pellets were resuspended in a solution containing
25% sucrose, 20 mM Tris-HCl, and 0.5 mM EDTA (pH 7.5). This suspension was
layered on top of 30, 35, 40, 45, 50, and 55% sucrose layers and centrifuged at 100,000 x
g for 6 h at 4°C (Ward et al., 2000). The visible cytoplasmic membrane layer and the
outer membrane layer (inner membrane-depleted layer) were extracted with a syringe,
concentrated by centrifugation, and washed three times with 20 mM Tris-HCl (pH 7.5) to
remove sucrose and EDTA. Outer membrane fractions were washed with 5 M urea to
remove peripheral or aggregated proteins (Marani et al., 2006).
2.2.5. Western blotting
Protein expression was determined by immunoblotting. Samples were mixed with
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sodium dodecyl sulfate (SDS) in loading dye but were not boiled. Proteins were separated
by SDS-polyacrylamide gel electrophoresis (PAGE) and transferred to nitrocellulose
membranes (0.2 µm, Pall) by using a MiniVE semiwet blotter (GE Healthcare) at 100
mA for 2 h. Prestained protein marker (New England Biolabs) was used to confirm
transfer and measure the apparent molecular masses of proteins detected by
immunoblotting. The membrane was blocked with 3% bovine serum albumin in Tris-
buffered saline containing 0.05% Tween 20. For the analysis of HSV epitope-tagged
proteins, blots were incubated with HSV-tag monoclonal antibody (1:2,000 dilution;
Novagen), followed by goat anti-mouse immunoglobulin G (IgG) secondary antibody
conjugated to horseradish peroxidase (1:2,500 dilution; Pierce) for 1 h at room
temperature. The affinity-purified NusA-HSV-His6 protein from E. coli BL21(DE3)
(pET-43.1b) cells was used as a positive control. For the analysis of E. coli LepA-S-Tag
or OmpX-S-Tag proteins, blots were incubated with a mouse monoclonal antibody raised
against the S-Peptide (1:1,000 dilution; Affinity BioReagents), followed by detection
with goat anti-mouse IgG as described above. Blots were developed by using a Super
Signal West Pico mouse IgG detection kit (Pierce). Chemiluminescence was detected by
using an Image Station 4000R instrument (Carestream Health) with Molecular Imaging
software (version 4.0).
2.2.6. Cellular transport assays
A suspension of 3 x 109 E. coli cells was prepared in 0.1 ml of E medium
containing 73 mM K2HPO4, 17 mM Na2HPO4, 0.8 mM MgSO4, and 10 mM sodium
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citrate at 37°C. Transport was initiated by adding 1 mM L-arginine-HCl with 2 µCi of L-
[2,3,4,5-3H]arginine. After 10 min of incubation, 1 ml of 0.1 M LiCl was added to stop
the reaction, and cells were collected by vacuum filtration on a polyethersulfonate
membrane filter (0.2 µm, 25-mm diameter; Pall). The filters were washed with 2 ml of
0.1 M LiCl and then removed for liquid scintillation counting (Smith and Graham, 2008).
2.2.7. Arginine-dependent acid resistance assay
E. coli DEG0147 cells transformed with the indicated plasmids were grown in
Luria-Bertani broth with 0.15% L-arabinose at 37°C. Approximately 3 x 107 E. coli cells
in 20 µl of medium were added to 2 ml of E medium (pH 2.5) supplemented with 1.5
mM L-arginine at 37°C.  E media without arginine was used as a control.  Survival after
1 h of acid shock treatment was determined by drawing samples immediately after adding
cells to the acid shock media and 1 hour after adding cells.  Serial dilutions were made
immediately in cold E media adjusted to pH 7 and the samples were plated on LB plates
with ampicillin (100 µg/ml).  After overnight incubation at 37°C colony-forming units
(CFU) were counted and averaged from 3 plates for each time point for each sample.
The survival rate is the percentage of viable cells detected after 1 h, relative to the
number of viable cells detected immediately after the introduction of cells to acid shock
medium (Smith and Graham, 2008).
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2.3. RESULTS
2.3.1. Expression of AaxC and localization to the cytoplasmic membrane
The E. coli strain DEG0147 (ΔadiAYC::kan) was constructed by deleting the adi
operon which encodes the arginine-agmatine antiporter AdiC, the PLP-dependent
arginine decarboxylase AdiA, and the putative regulatory protein AdiY.  This mutant is
defective for the E. coli arginine-dependent acid resistance system and was used to
heterologously express the chlamydial aax genes in the absence of any other system for
arginine-agmatine exchange.  DEG0147 grows normally in LB medium under aerobic
conditions and is only defective for arginine-dependent acid-resistance (Smith and
Graham, 2008).
The aaxC gene from C. pneumoniae was fused to a carboxy-terminal HSV
epitope tag sequence in the vector pDG133 and was subcloned behind a PBAD promoter in
pDG194.  E. coli DEG0147 cells transformed with either pDG194 or pBAD/HisA as a
negative control were grown aerobically, harvested and lysed, and the membranes were
separated by sucrose-density gradient centrifugation as described in the experimental
procedures.  The proteins were separated by SDS-PAGE and analyzed by Western
blotting with a monoclonal HSV antibody (Figure 2.1).  Compared with the pBAD/HisA
control the cells expressing AaxC-HSV showed a new band with an apparent molecular
mass of 41 kDa (56.1 kDa calculated).  This discrepancy between the apparent and
calculated molecular mass of AaxC-HSV is consistent with other integral membrane
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proteins, which are known to migrate unusually fast during SDS-PAGE.  The E. coli
AdiC protein has an observed molecular mass of 34 kDa but a calculated molecular mass
of 46.8 kDa (Fang et al., 2007).  The AaxC-HSV band was observed only in the
cytoplasmic membrane fraction of the cells’ total membrane component separated by
sucrose-density gradient centrifugation (Smith and Graham, 2008).
To further establish that AaxC localizes to the cytoplasmic membrane, the E. coli
strain BW25113 (ΔaraBADAH33) was transformed with pDG194 as well as pDG552 and
pDG561.  The outer membrane marker protein OmpX and the cytoplasmic membrane
marker protein LepA were expressed from these two plasmids, respectively.  Both marker
proteins were fused to a carboxy terminal S-Tag sequence so that they could be identified
by Western blot using a monoclonal antibody raised against the S-Peptide.  The AaxC-
HSV protein colocalized with LepA and no AaxC was identified in the outer membrane
fraction (Smith and Graham, 2008).
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Figure 2.1.  AaxC-HSV localizes to the cytoplasmic membrane
Western blots show the AaxC-HSV protein was expressed in the cytoplasmic membrane
of E. coli. (A) A 41-kDa band corresponding to AaxC-HSV detected using an anti-HSV
monoclonal antibody. (B) A 69-kDa band corresponding to the E. coli LepA-S-Tag
protein, detected using an S-peptide monoclonal antibody. The same protein samples
were used for both immunoblots. Lane 1 contains the total membrane fraction from E.
coli BW25113(pBAD/HisA) cells. Sucrose density-gradient centrifugation was used to
separate the total membrane fraction from BW25113 (pDG194, pDG552, pDG561) cells
into an outer membrane fraction (lane 2), a cytoplasmic membrane fraction (lane 3), and
a high-density pellet (lane 4). The LepA protein identified in the high-density pellet may
be associated with ribosomes (Qin et al., 2006). The immunoblot with S-peptide
monoclonal antibody also identified a 46-kDa band in the cytoplasmic membrane fraction
that may represent a degradation product of LepA (data not shown).
2.3.2. Arginine uptake by AaxC in whole cells
E. coli DEG0147 cells were transformed with pDG170, which expressed the
untagged AaxC from the PBAD promoter and these cells were used to analyze the uptake
of arginine by AaxC in the absence of arginine decarboxylase activity.  The E. coli AdiC
protein was reported to exchange intracellular arginine for extracellular arginine without
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AdiA activity and therefore AaxC was expected to demonstrate similar activity (Fang et
al., 2007).  Washed cells mixed with 1 mM L-[3H]arginine and incubated for 10 minutes
at 37°C were collected by filtration and after additional washes the radiolabel on the filter
was measured by liquid scintillation counting (Figure 2.2).  Radiolabel retained on the
filters by cells not expressing AaxC was not significantly different from the background
radiolabel for reaction mixtures without cells that were used as a negative control.  Cells
expressing AaxC showed a significant increase in the amount of radiolabel retained on
the filters with a maximum level of arginine uptake observed from pH 5 to 6.  While
significant uptake still occurred at pH 7, none was observed at pH 4 or lower (Smith and
Graham, 2008).  This contrasts with E. coli AdiC, which showed optimal uptake at pH
2.5 (Fang et al. 2007).  It is likely that some AaxC-mediated arginine-arginine exchange
may still occur at a low pH, but it was not detectable over background radiolabel on the
filters.
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Figure 2.2.  Arginine uptake by AaxC
Expression of aaxC promoted arginine uptake. E. coli DEG0147 (pDG170) cells
expressing aaxC alone optimally transported L-[U-14C]arginine from pH 5 to 6 ().
Arginine transport by E. coli DEG0147 (pBAD/HisA) cells (•) was not significantly
different from background levels due to membrane binding of arginine in control
reactions without cells ( ). The net radioactivity measured in reactions containing
DEG0147 (pDG170) cells at pH 5 corresponds to 0.4% arginine uptake. No net arginine
transport was detected below pH 5 in these cells.
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2.3.3. Inhibition of arginine uptake by AaxC
Various potential inhibitors of AaxC were tested using the assay described above.
As before, AaxC was expressed from pDG170 in DEG0147 and cells were collected by
filtration after incubation with radiolabeled arginine.  Additionally, potential inhibitors
were added to the reaction mixtures to determine their effect on arginine uptake.  L-
argininamide, although shown to inhibit AaxB activity (Giles and Graham, 2007), had no
effect on arginine uptake by AaxC.  The only tested inhibitors that significantly reduced
arginine uptake were L-canavanine and D-arginine, which reduced uptake to 18% and
43%, respectively (Smith and Graham, 2008).  D-arginine was not reported to inhibit
AaxB activity and L-canavanine was shown to be a substrate for AaxB (Giles and
Graham, 2007).
2.3.4. Complementation of acid resistance with AaxBC
E. coli cells expressing the adiAYC genes are able to exchange arginine for
agmatine produced by the arginine decarboxylase AdiA using the AdiC arginine-
agmatine antiporter.  This is just one of the systems used by wild type E. coli to pair
amino acid uptake and decarboxylation for the purpose of increasing their cytoplasmic
pH and inverting their membrane potential to resist acid shock.  These systems are
expressed in late stationary phase under anaerobic acidic conditions and exist to allow E.
coli to survive in the stomach before colonizing the gut (Richard and Foster, 2004).
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In E. coli DEG0147 the deletion of adiAYC eliminates arginine-dependent acid
resistance and in DEG0147 (pBAD/HisA) minimal survival was observed after 1 hour at
pH 2.5 in the presence or absence of arginine (Figure 2.3).  When AaxBC was expressed
in DEG0147 (pDG379) under the same conditions, acid survival over 1 hour was
observed to increase by more than 3 orders of magnitude in the presence of 1.5 mM L-
arginine, yielding almost 30% survival, which is comparable to wild type E. coli.  In the
absence of arginine, this increase in survival was lost and cells expressing AaxBC fared
no better than E. coli DEG0147 (pBAD/HisA).  The complete aaxABC gene cluster was
also expressed in E. coli DEG0147 (pDG484) but there was no significant increase in
survival when compared with cells expressing AaxBC alone (Smith and Graham, 2008).
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Figure 2.3.  Complementation of acid resistance in E. coli using aax genes
Expression of the C. pneumoniae aaxBC genes restored arginine-dependent acid
resistance in E. coli DEG0147. Cells containing pBAD/HisA (vector control), pDG379
(aaxBC), or pDG484 (aaxABC) were incubated in E medium at pH 2.5 for 1 h in the
absence (light gray bars) or presence (dark gray bars) of 1.5 mM L-arginine. The mean
survival rates and standard deviations are shown for each assay repeated in triplicate.
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2.4. DISCUSSION
The AaxC protein from C. pneumoniae is involved in taking arginine into the cell,
as was demonstrated by heterologously expressing AaxC in E. coli mutants unable to
express their own equivalent arginine-agmatine antiporter AdiC.  No arginine
biosynthetic proteins are known to be encoded by any chlamydial genomes so chlamydial
cells must take up arginine from the host cells they infect.  C. pneumoniae has an operon
regulated by the ArgR repressor that encodes a putative ABC-type arginine transporter
(Schaumburg and Tan, 2006).  This transporter is probably responsible for the uptake of
arginine required for protein synthesis.  The Aax system does not seem to be involved in
taking up arginine for this purpose and instead converts arginine to agmatine, which is
then exported from the cell and into the host environment (Smith and Graham, 2008,
Chapter 3).
E. coli AdiA and AdiC function together as an arginine-agmatine exchange system
for the purpose of enhancing survival in a low pH environment.  To determine if C.
pneumoniae AaxB and AaxC could serve the same function as AdiA and AdiC, an E. coli
mutant was used which was unable to express adiAYC and was therefore defective for
arginine-dependent acid resistance.  In complementation experiments using these cells
transformed with plasmids expressing the chlamydial aaxBC or aaxABC it was observed
that the Aax system from C. pneumoniae was able to fully rescue acid resistance function
in the presence of arginine.  Without arginine in the media no such rescue was observed,
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indicating that the system for acid resistance is fully dependent on arginine, as was
predicted.  The outer membrane porin AaxA had no significant effect on acid resistance,
even though it is able to facilitate the uptake of arginine, as detailed in later chapters.
However this is not a contradiction as AaxA loses activity under low pH conditions
(Chapter 4).  The ability of AaxB and AaxC to rescue acid-resistance function may not be
relevant to the role of this system in C. pneumoniae, particularly if AaxA, with its higher
pH optimum is an integral part of the same system.  Because C. pneumoniae is not
believed to encounter extremely low pH conditions during infection AaxABC may have a
different role entirely.
The Aax system is functional for acid-resistance when expressed in E. coli even
though arginine uptake assays using heterologously expressed AaxC showed no activity
above background at pH 2.5.  This suggests that arginine-agmatine exchange driven by
the activity of an arginine decarboxylase should be much more efficient than arginine-
arginine exchange and assays for arginine-agmatine exchange in the next chapter confirm
this result.  Arginine-arginine exchange can be partially inhibited by the addition of D-
arginine or L-canavanine with the later being most effective.  Other arginine analogs that
were tested did not result in significant inhibition of arginine uptake by AaxC, suggesting
that they are not taken up by AaxC and therefore cannot compete with L-arginine.  The
fact that D-arginine is able to partially inhibit arginine uptake suggests that AaxC does
not discriminate based on stereochemistry.  Since AaxC did not import any of the other
arginine-analogs tested, it can be inferred that AaxC is very specific in its activity.
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AaxC is an amino acid transport protein localized to the cystoplasmic membrane.  It
can function with the chlamydial arginine decarboxylase AaxB to rescue acid resistance
function at pH 2.5 and it can exchange radiolabeled extracellular arginine for unlabeled
intracellular arginine.  AaxC can be partially inhibited only by L-canavanine and D-




AaxBC and AaxABC as a system for arginine-agmatine exchange
3.1. OVERVIEW
If AaxC from C. pneumoniae functions as an arginine-agmatine antiporter like
AdiC in E. coli, it should be possible to detect agmatine excreted from E. coli cells
expressing AaxC and the AaxB decarboxylase together.  It was shown in the last chapter
that arginine can be transported by AaxC and that AaxC and AaxB can function together
as a system for extreme acid-resistance in E. coli.  However, significant inhibition of
uptake by AaxC was not detected when agmatine was tested as an inhibitor.  This
suggests either that agmatine can only be transported by AaxC from the cytoplasm to the
extracellular environment and not in the reverse direction, or else that AaxC does not
transport agmatine at all and is therefore not an arginine-agmatine antiporter like AdiC.
As a third option, the high background observed in the arginine uptake assays obscured
the effects of agmatine as an inhibitor for arginine uptake by AaxA (Smith and Graham,
2008).  There is precedence for asymmetric substrate affinity in antiporters so it would
not be unexpected if agmatine is taken up more efficiently from the cytoplasm than the
external environment (Goldfarb and Nord, 1987, Dierks and Krämer, 1988).
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To find the answer to the question of whether or not AaxC is an arginine-
agmatine antiporter two general approaches were used.  In both cases Aax proteins were
expressed in E. coli mutants unable to express their native Adi proteins for arginine-
agmatine exchange.  For the first method, these E. coli cells were incubated in media
containing L-arginine spiked with L-[3H]arginine.  The cells were spun down and the
supernatants containing radiolabeled arginine, agmatine, or a mixture of both were
separated by strong cation-exchange HPLC and fractions were collected for liquid
scintillation counting.  UV chromatograms were compared with the distribution of
radiolabel in the collected fractions to determine if arginine was being decarboxylated to
produce agmatine.  The production and export of agmatine in cells expressing AaxC with
AaxB but not in negative controls supported the hypothesis that AaxC is an arginine-
agmatine antiporter (Smith and Graham, 2008).
For the second method L-[14C]arginine was used and the radiolabled CO2
produced by the decarboxylation of arginine was collected on barium hydroxide soaked
filter paper discs at the top of the reaction tubes and quantified by liquid scintillation
counting.  For these assays the production of CO2 was used as a proxy for arginine uptake
and decarboxylation by the Aax proteins.  Unlike the arginine uptake assays used
previously to examine AaxC the whole cell decarboxylase assay produces minimal
background and it is much less time consuming than the HPLC method.  Although
arginine uptake by AaxC is not being examined directly, decarboxylation of arginine by
AaxB is dependent on the uptake of arginine into the cells.  Arginine decarboxylase
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activity in whole cells without AaxC is minimal, although native E. coli transporters may
allow some arginine uptake.  AaxC dramatically increases whole cell decarboxylase
activity over this background level, confirming its role in arginine uptake (Smith and
Graham, 2008).
The dependence of this system on various ions present in the media was examined
by using various buffers.  Arginine uptake by AaxC was observed to be unaffected by the
presence or absence of chloride, potassium, sodium, phosphate, or citrate, which contrasts
with some other transport proteins which are dependent on certain ions for activity.
AdiC, for example, requires the transport of chloride ions to relieve excessive buildup of
positive charge caused by the decarboxylation of arginine (+1) to yield agmatine (+2).
The internal positive charge created by arginine agmatine exchange is essential to acid
survival but it must be possible to restore the internal negative charge to the cell after it
has escaped the low pH environment.  Chloride uptake may be important for doing so.
However, if limiting excessive positive charge during acid challenge is a factor for
arginine-agmatine exchange in E. coli, this does not seem to be the case for chlamydia
(Fang et al., 2007).
As with the previously described AaxC arginine uptake assays, various arginine
analogs were examined for their ability to inhibit arginine uptake and decarboxylase
activity in whole cells.  Because of the requirement for substrate uptake by a transporter
for decarboxylase activity in the cell, inhibition of AaxB should only occur if the AaxC
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antiporter is able to transport the inhibitor.  It was previously shown that L-argininamide
was an inhibitor for AaxB (Giles and Graham, 2007).  However, because AaxC does not
transport L-argininamide, as shown in the previous chapter, there was no significant
inhibition of arginine decarboxylase activity in assays using whole cells.  As expected, D-
arginine and L-canavanine were able to inhibit arginine uptake and decarboxylation,
which is consistent with results for arginine uptake by AaxC detailed in the previous
chapter.  Some inhibition by agmatine was observed using these assays, although it was
small and had not been detectable using the arginine uptake assays with AaxC alone.
With the AaxB arginine decarboxylase to drive arginine uptake much higher rates were
observed and combined with an assay with much lower background than the one used
before this result suggests that agmatine and arginine are able to compete for uptake by
AaxC, even if agmatine is not a very effective inhibitor.  This may be the result of a
reduced affinity for agmatine at the external transport site compared to the cytoplasmic
site (Smith and Graham, 2008).
AaxA is a newly discovered outer membrane porin, which will be detailed in
chapter 4.  As previously mentioned, it did not significantly enhance acid-survival rates
in E. coli at pH 2.5 but it was observed to enhance whole cell arginine decarboxylase
activity by a significant degree under higher pH conditions.  This suggests that AaxA,
AaxB, and AaxC may work together as an efficient system for arginine-agmatine




The CPn1033-CPn1032-CPn1031 cluster was amplified by PCR using the primers
5CPn1033Nc and 3CPn1031X. The product was ligated between the NcoI and XhoI sites
of pBAD/HisA to produce pDG484. The CPn1033 gene was amplified using the primers
5CPn1033Nc and 3CPn1033Not and ligated between the NcoI and NotI sites of pDG366
to produce pDG512 (Smith and Graham, 2008). Recombinant DNA was sequenced at the
Institute for Cellular and Molecular Biology Core Labs DNA Sequencing facility
(University of Texas at Austin). Both the CPn1031 and the CPn1033 gene sequences
from C. pneumoniae K6 were identical to their orthologous sequences reported for C.
pneumoniae CWL029 (GenBank accession numbers AE001363.1 and AE002161.1)
(Read et al., 2000).
3.2.2. Product analysis
The unlabeled agmatine produced by transport and arginine decarboxylation
reactions was identified by liquid chromatography-electrospray ionization mass
spectrometry (LC-MS) as the trifluoroacetyl derivative. A reaction mixture (300 µl)
containing 3 x 109 DEG0147(pDG484) cells with 25 mM L-arginine and ammonium
acetate buffer (pH 4) was incubated for 2 h at 37°C. Cells were removed by
centrifugation, and the solution was evaporated to dryness under nitrogen. Trifluoroacetyl
derivatives were prepared using trifluoroacetic anhydride and analyzed by LC-MS in the
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positive ion mode, as described previously (Graham et al., 2008).  Tandem mass spectra
(MS/MS) were acquired by using collision-induced dissociation of the [MH]+ ions. Peaks
corresponding to the molecular ions ([MH]+) are shown first, followed by characteristic
ion fragments listed in decreasing order of intensity. The acyl derivative of L-arginine
eluted at 2.91 min producing peaks at 271 and 251 m/z; MS/MS of the ion at 271 m/z
produced peaks at 213, 255, and 230 m/z. The acyl derivative of agmatine eluted between
2.9 and 3.9 min, producing peaks at 227, 169, and 185 m/z; MS/MS of the ion at 227 m/z
produced peaks at 169, 211, and 186 m/z.
For radiolabeled product analysis, reaction mixtures (2 ml) contained 109 cells,
suspended in E medium at pH 2.5 or 5.0. Mixtures were preincubated at 37°C for 10 min
before reactions were initiated by the addition of 1 mM L-arginine and 4 µCi of L-
[2,3,4,5-3H]arginine (50 Ci mmol–1; American Radiolabeled Chemicals). Samples were
removed immediately after initiation and again after 2 h of incubation: these were
centrifuged at 17,000 x g for 5 min to remove cells. Unlabeled agmatine was added to
samples as a carrier. Supernatants were applied to a Luna strong cation-exchange high-
pressure liquid chromatography (HPLC) column (150 by 4.6 mm, 5 µm; Phenomenex)
with a guard column (4 by 3 mm); equilibrated at 35°C in mobile phase buffer containing
50 mM KH2PO4, 100 mM K2SO4, 10% CH3CN, and water; and adjusted to pH 7.2 with
phosphoric acid. Isocratic elution with this buffer was used to separate compounds at a
flow rate of 1 ml min–1. Fractions (1 ml) were collected, and the radioactivity was
determined by liquid scintillation counting. Using this method, arginine eluted at 1.8 min
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and agmatine eluted at 6.1 min.
3.2.3. Arginine uptake and decarboxylation assays by whole cells
Approximately 3 x 109 cells were collected by centrifugation at 18,000 x g for 10
min. These cells were suspended in E media adjusted to the indicated pH (Vogel et al.,
1956).  Suspensions were prewarmed at 37°C, and the reactions were initiated by the
addition of 1 mM L-arginine and 20 nCi of L-[U-14C]arginine (305 mCi mmol–1; GE
Healthcare) at 37°C for 15 min.  Reactions were carried out in 1.5 ml polypropylene
microcentrifuge tubes with filter paper discs soaked in saturated barium hydroxide at the
top (Giles and Graham, 2008). Reactions were terminated by the addition of 100 µl of 4
M HCl. These solutions were heated at 70°C for 15 min, releasing 14CO2 that was trapped
by the barium hydroxide-soaked filter paper discs and the captured radioactive product
was measured by liquid scintillation counting (Giles and Graham 2007, Smith and
Graham, 2008).
3.2.5. Cell free decarboxylase assays
Cells were suspended in 20 mM Tris-HCl buffer (pH 7.5), and lysed by sonication
on ice. Centrifugation at 18,000 x g for 15 min removed insoluble particles. Total protein
concentrations of these cell extracts were determined using the Bradford assay (Pierce)
with bovine serum albumin as a standard. ArgDC activity in cell lysates was determined
by using the 14CO2 capture assay described previously (Giles and Graham, 2007, Smith
and Graham, 2008).
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3.2.6.  Inhibition of AaxBC in whole cells and B in lystaes
Potential inhibitors of arginine transport or decarboxylation were added to whole-
cell assays containing 0.5 mM L-arginine and 20 nCi of L-[U-14C]arginine. The arginine
analogs screened at 2 mM concentrations were agmatine, L-arginine O-methyl ester, N-
acetyl L-arginine, NG-nitro-L-arginine methyl ester, D-arginine, L-argininamide,




Whole cells expressing the arginine decarboxylase AaxB and the arginine
agmatine antiporter AaxC from pDG379 were incubated at 37°C in reaction mixtures
containing L-[3H]arginine for 2 hours to allow for the production of agmatine.  LC-MS
analysis of the trifluoroacetyl derivatives of the extracellular reaction products after this
incubation identified the presence of significant amounts of agmatine as well as
unconverted arginine.  Radiolabeled arginine and agmatine were separated from the
extracellular reaction volume using strong cation exchange HPLC and the collected
fractions were analyzed by liquid scintillation counting.  The amount of radiolabel in
each fraction was compared with the UV chromatogram showing peaks corresponding to
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unlabeled carrier arginine and agmatine to determine how much arginine was converted
to agmatine (Figure 3.1) (Smith and Graham, 2008).
Two strains of E. coli were used for this assay, DEG0147 (ΔadiAYC::kan) and
DEG0100 (ΔadiC1::kan), both transformed with pDG379 to express AaxB and AaxC or
with pBAD/HisA as a negative control.  Because E. coli AdiA is not expressed from cells
grown aerobically it was expected that there would be no significant difference in
agmatine production whether DEG0147 or DEG0100 was used for the assay (Smith and
Graham, 2008).
Although AdiA and AdiC are most efficient at an extracellular pH of 2.5 (Figure
3.2), maximum conversion of arginine to agmatine in whole cells expressing AaxB and
AaxC occurred at pH 5 where E. coli DEG0147 (pDG379) converted 50% of arginine to
agmatine (Figure 3.5).  These cells converted only 20% of arginine to agmatine at pH 2.5
(Figure 3.4).  No agmatine production was detected in control reactions using DEG0147
(pBAD/HisA) (Figure 3.3) and all collected radiolabel corresponded to the arginine peak
(Smith and Graham, 2008).
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Figure 3.1.  Reaction product analysis by HPLC
E. coli cells expressing aaxBC converted tritium-labeled L-arginine to agmatine.
Separation of radiolabeled compounds by cation-exchange HPLC from a control mixture
containing arginine (peak 1) and agmatine (peak 2) (top figure) is compared to a sample
taken from a reaction with E. coli DEG0147 (pDG379) cells at pH 2.5 (bottom figure).
Similar results were obtained for reactions using all other strains. Unlabeled agmatine
was added as a carrier for product analysis. The second chromatogram shows the UV
absorbance of arginine (peak 2) and agmatine (peak 7), which correlates with
radioactivity (CPM) determined by liquid scintillation counting of 1-ml fractions as
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Figure 3.2.  Conversion of arginine to agmatine in wild type E. coli.
E. coli MG1655 was used as the wild type control for the conversion of arginine to
agmatine by whole cells.  This strain expresses adiAYC and has an active AdiA arginine
decarboxylase as well as an active arginine agmatine antiporter.  The radiolabel in the
collected samples corresponds to both the arginine peak and the agmatine peak after 2
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Figure 3.3.  Conversion of arginine to agmatine is not detected in the DEG0147
negative control.
DEG0147 is a mutant derived from MG1655 that does not express adiAYC.  Without
AdiC and AdiA, this strain is unable to convert arginine to agmatine and as a result all
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Figure 3.4. AaxB and AaxC can convert arginine to agmatine in E. coli at pH 2.5.
With the expression of AaxB and AaxC from pDG379 in E. coli DEG0147, to agmatine
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Figure 3.5.  Conversion of arginine to agmatine by AaxB and AaxC is enhanced at
pH 5.0.
At pH 5 conversion of arginine to agmatine by AaxB and AaxC is dramatically improved
over the activity observed at pH 2.5, indicating that the chlamydial system has a higher
optimal pH than that of E. coli.
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3.3.2. Uptake and decarboxylation by Aax proteins
To simply measure arginine agmatine exchange by the Aax proteins in whole
cells the decarboxylation of L-[14C]arginine was used as a proxy.  The decarboxylation
reaction produces 14CO2, which can be trapped on a barium hydroxide-saturated filter
disc at the top of the reaction vial after acidifying and heating the reaction mixture.  The
radiolabel on each disc was measured using liquid scintillation counting.  Reactions were
carried out at a range of pH values using E. coli DEG0147 transformed with either the
empty vector pBAD/HisA, aaxB in pDG339, aaxBC in pDG366, or aaxABC in pDG484
(Smith and Graham, 2008).
The negative control cells carrying pBAD/HisA showed no detectable
decarboxylase activity, as expected in a background lacking the E. coli arginine
decarboxylase AdiA (Figure 3.6).  Expression of AaxB resulted in a small but significant
amount of arginine decarboxylase activity but this activity was limited by the ability of
the cells to import arginine using the native transport systems expressed under reaction
conditions.  Expression of AaxC together with AaxB resulted in a significant increase in
activity over AaxB alone, approximately four times the arginine decarboxylase activity
observed in the absence of the transport protein.  Expression of the outer membrane
protein AaxA along with AaxB and AaxC resulted in an even more impressive fifteen-
fold increase in activity over AaxB alone (Smith and Graham, 2008).  AaxA’s role will
be explored later in this dissertation (This work, Chapter 3).
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In whole cell assays the arginine decarboxylase activity by AaxBC was observed
to be greatest over of a pH range of 3 to 5 (Figure 3.6).  This is consistent with the results
for agmatine production detected by HPLC analysis.  In both of these experiments
arginine agmatine exchange by AaxC is driven by the decarboxylation of arginine by
AaxB.  In the previously discussed arginine uptake assays using AaxC in the absence of
AaxB the optimum pH range was somewhat more basic with no detectable uptake at or
bellow pH 4 and no significant drop in activity at pH 6 (Smith and Graham, 2008).  The
arginine decarboxylase AaxB was previously reported to have optimum activity at pH 3.4
which must cause the optimal pH of the AaxBC system as a whole to be lower with a
significant drop in activity by pH 6 and almost no detectable activity at pH 7 (Giles and
Graham, 2007, Smith and Graham, 2008).
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Figure 3.6.  Arginine decarboxylase activity assays using whole cells
E. coli DEG0147 (ΔadiAYC::kan) cells expressing the aaxABC genes transport L-
arginine and catalyze its decarboxylation. Reactions containing 3 x 109 cells were
incubated with 0.5 mM [U-14C]-L-arginine for 15 min at 37°C in 100 µl of E medium
with buffer at the indicated pH. 14CO2 was collected and analyzed as described in
Materials and Methods. The DEG0147 strains contained empty vector pBAD/HisA (),
aaxB in pDG339 (•), aaxBC in pDG366 (), and aaxABC in pDG484 (). Error bars
show the standard deviations from the mean of triplicate experiments.
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3.3.3. Comparison with lysates
The whole cell decarboxylase assay results described above still leave the
question of whether increased decarboxylase activity when AaxC and AaxA are
expressed may only be an artifact caused by enhanced expression of AaxB from these
plasmids.  To examine this possibility decarboxylase assays were performed using total
cell lysates, eliminating the effects of any transport proteins from the results (Figure 3.7).
From these tests it was observed that there was no detectable arginine decarboxylase
activity in lysates produced from DEG0147 (pBAD/HisA).  The difference in
decarboxylase activity between lysates from DEG0147 (pDG339) expressing AaxB and
DEG0147 (pDG 366) expressing AaxBC was not statistically significant but the lysates
from DEG147 (pDG484) expressing AaxABC showed activity 63% higher than that of
cells expressing AaxB alone.  Therefore, at least in DEG0147 (pDG484) increased AaxB
expression contributes to the increase in whole cell decarboxylase activity that was
observed.  However, a 63% increase in decarboxylase activity cannot explain the 1500%
increase in arginine uptake and decarboxylation observed in cells expressing AaxABC
when compared with AaxB alone.  Thus AaxA as well as AaxC clearly enhance activity
in whole cells, owing to their roles in arginine uptake (Smith and Graham, 2008).
To determine if the composition of the reaction medium has any effect on the
activity of AaxABC different reaction buffers were tested (Figure 3.8).  Potassium and
sodium salts were omitted in independent tests and citrate was replaced with tartrate
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buffer.  Additionally chloride ions were replaced with acetate.  None of these changes
resulted in any loss of activity suggesting that AaxABC is not dependent on any of these
ions (Smith and Graham, 2008).
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Figure 3.7.  Arginine decarboxylase activity assays using cell lysates
Cell-free lysates from DEG0147 cells carrying the indicated plasmids were assayed for
arginine decarboxylase activity at pH 4. No significant decarboxylase activity was
detected in lysates of DEG0147 (pBAD/HisA) cells. Error bars show the standard
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Figure 3.8.  Arginine uptake and decarboxylation by AaxBC is not affected by
changes in buffer composition.
E. coli DEG0147 cells carrying pDG366 containing aaxBC were used for decarboxylase
assays in various buffers adjusted to pH 4.  E media contains 73 mM K2HPO4, 17 mM
Na2HPO4, 0.8 mM MgSO4, and 10 mM sodium citrate.  Buffer without potassium
contained 90 mM Na2HPO4, 0.8 mM MgSO4, and 10 mM sodium citrate.  Buffer without
sodium contained 90 mM K2HPO4, 0.8 mM MgSO4, and 10 mM sodium citrate.  Buffer
without citrate contained 100 mM sodium potasium tartrate and 0.8 mM MgSO4.  Buffer
without chloride was regular E media adjusted to the desired pH with acetate instead of
HCl.  Activity is given in µmol min-1. Error bars show the standard deviations from the
mean of triplicate experiments.
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3.3.4. Inhibitors
It was previously reported that the arginine decarboxylase AaxB was inhibited by
L-argininamide while L-canavanine was used as an alternative substrate (Giles and
Graham, 2007).  The arginine agmatine- antiporter AaxC is not inhibited by L-
argininamide but it is inhibited by L-canavanine as well as D-arginine.  Various arginine
analogs were tested as potential inhibitors using the whole cell decarboxylase assay with
E. coli DEG0147 (pDG366) cells at pH 6 (Figure 3.9).  The arginine analogs tested were
agmatine, L-arginine O-methyl ester, N-acetyl L-arginine, NG-nitro-L-arginine methyl
ester, D-arginine, L-argininamide, cadaverine, L-citrulline, L-homoarginine, L-histidine,
L- lysine, and L-ornithine.  Of these only L-canavanine and D-arginine were effective
inhibitors, demonstrating 30% and 81% activity, respectively.  These results agree with
the inhibitor data for the arginine uptake assays and indicate that these compounds are
imported by AaxC.  Agmatine also showed some ability to inhibit arginine uptake,
resulting in 86% activity.  This contrasts with the results for inhibition of arginine uptake


































Figure 3.9.  L-canavanine and D-arginine inhibit arginine uptake and
decarboxylation by AaxBC.
E. coli DEG0147 (pDG366) cells were incubated with 2 mM concentrations of the
indicated inhibitors before the addition of the arginine substrate.  Whole cell
decarboxylase assays were otherwise carried out as previously described.  Potential
inhibitors are displayed in order from least effective to most effective.  L-canavanine was
the most effective inhibitor tested.
3.4.  DISCUSSION
AaxC is an amino acid transport protein capable of importing arginine into the
cell while exporting agmatine.  In assays using E. coli cells expressing AaxB and AaxC,
separation of the radiolabeled compounds in the media by strong cation exchange HPLC
after the removal of cells showed that agmatine was not only being produced, it was
being exported into the extracellular environment.  The production and export of
agmatine as observed from the results of these assays shows that pH 2.5, the optimum pH
for arginine-agmatine exchange by AdiA and AdiC, is not the optimum pH for the
chlamydial proteins.  AaxB has previously been shown to have a low optimal pH of 3.4
(Giles and Graham, 2007).  In spite of this very low pH optimum, agmatine production
by AaxBC was much higher at an extracellular pH of 5 than pH 2.5.  This result is
consistent with the optimum pH of AaxC for arginine uptake as detailed in the previous
chapter.  AaxC was able to exchange radiolabeled extracellular arginine for unlabeled
intracellular arginine most efficiently at pH 5 and based on the HPLC data, which shows
AaxBC operating most efficiently at pH 5, it is apparent that uptake by AaxC is the
limiting step.
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Arginine-agmatine exchange by AaxBC is still significant at pH 2.5, as evidenced
in the previous chapter where this system was shown to rescue acid survival in E. coli
adiAYC mutants.  Arginine uptake by AaxC must be sufficient for acid-resistance even at
this pH but the fact that its pH optimum is so much higher than that of AdiC suggests that
AaxC did not evolve to handle extremely low pH environments.  This is consistent with
the current understanding of chlamydial pathogenesis in which this organism does not
have to cope with such a low pH.
Whole cell decarboxylase assays showed that arginine decarboxylation by AaxB
in E. coli is significantly enhanced by the transport activity of AaxC.  This increase is
most pronounced between pH 3.0 and pH 5.0, and there is no significant difference in the
activity across this range.  There is some observable arginine decarboxylase activity in
the absence of the AaxC transporter, probably due to some background level of arginine
uptake by native E. coli amino acid transporters. The whole cell arginine decarboxylase
activity is increased 4-fold by AaxC, suggesting a large enhancement of arginine uptake
across the cytoplasmic membrane by this transporter.    Importantly, there is no detectable
activity in control cells that do not express the chlamydial proteins.  This shows that there
is no background arginine decarboxylase activity by any E. coli enzymes under the
conditions tested.
The outer membrane porin AaxA was observed to enhance the uptake and
decarboxylation of arginine in whole cells by an additional 4-fold over AaxBC.  By
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facilitating arginine diffusion through the outer membrane AaxA seems to contribute to
the chlamydial arginine-agmatine exchange system.  AaxA will be investigated more
thoroughly in chapter 4.
To insure that the observed effects by AaxC and AaxA were not merely the result
of increased AaxB expression from the plasmids, decarboxylase assays were performed
on cell lysates.  In these lysates AaxB arginine decarboxylase activity could be observed
without any dependence on porins or transport proteins and therefore it was expected that
the activity in the lysates would not change significantly whether cell expressing
aaxABC, aaxBC, or aaxB were used.  No significant difference was observable between
cells expressing AaxC and AaxB and those expressing AaxB alone, as expected.  This
confirms that the increase in whole cell decarboxylase activity was the result of enhanced
arginine uptake rather than higher levels of AaxB being expressed.  There was a small but
significant difference in the activity of cells expressing AaxA with AaxB and AaxC,
roughly 63% higher than cells expressing AaxB alone, but this does not account for the
observed increase in activity in whole cells expressing all 3 proteins, which was 1500%
when compared with AaxB alone.
Arginine uptake and decarboxylation by AaxBC in E. coli was observed to be
unaffected by the presence or absence of the components of the E media used for the
initial assays.  Replacing E media with tartrate buffer containing no citrate or phosphate
had no effect, nor did using acetate instead of HCl to adjust the pH of E media.
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Individually removing buffers with sodium or potassium ions likewise had no effect.
These results suggest that AaxC is not dependent on sodium, potassium, chloride,
phosphate, or citrate for activity, although all of these were originally present in the
medium used for whole cell decarboxylase assays.
Inhibition assays of arginine uptake in whole cells expressing AaxB and AaxC
gave similar results to those performed with AaxC alone.  L-Canavanine and D-arginine
were both shown to inhibit arginine uptake while other arginine analogs did not.
Agmatine, the arginine decarboxylation product, was not able to detectably inhibit AaxC
alone but because of the relatively low rate of arginine-arginine exchange compared with
arginine-agmatine exchange driven by AaxB and the high background of the arginine
uptake assay it is possible that there was some inhibition that was too slight to be
detected.  Using whole cell decarboxylase assays with E. coli cells expressing AaxB and
AaxC there was a small but significant amount of inhibition by agmatine.  Since HPLC
assays already showed that agmatine was exported in cells expressing AaxC, the ability
of extracellular agmatine to compete with arginine for uptake by AaxC is not suprising,
even if the level of inhibition is very low.
The results discussed in this chapter indicate that AaxABC is a system capable of
importing and decarboxylating arginine and exporting the decarboxylation product
agmatine.  This process is most efficient between pH 3 and pH 5 and it is not dependent
on the presence of specific ions in the medium.  Suprisingly AaxA, which has no analog
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in arginine-agmatine exchange systems in enterics, seems to have a large impact on the
activity of the Aax system, when expressed in E. coli.  This was unexpected, because E.
coli  outer membrane porins were predicted to take up sufficient arginine so that diffusion
of arginine across the outer membrane was not expected to be limiting.  AaxA will be





AaxA from C. pneumoniae is an outer membrane porin capable of enhancing the
arginine uptake and decarboxylation activity by AaxB and AaxC, as shown in the
previous chapter.  The further characterization of this protein will be detailed in this
chapter.  To verify that AaxA is in fact an outer membrane porin, the localization of
AaxA to the outer membrane was confirmed experimentally.  This result, together with
the activity shown in whole cell arginine decarboxylase assays using E. coli cells
expressing aaxABC is compelling, but if AaxA is an outer membrane porin capable of
enhancing arginine uptake through the outer membrane, it should not be dependent on
AaxB and AaxC to do so.  Therefore, wild type E. coli and E. coli porin mutants were
used in whole cell arginine decarboxylase assays to show that AaxA can enhance
arginine uptake and decarboxylation activity by AdiA and AdiC.
With AaxA’s activity confirmed independent of the other chlamydial proteins it was
next compared with the major outer membrane protein (MOMP) from C. pneumoniae.
MOMP is a general porin and is able to enhance arginine uptake by AdiA and AdiC in a
manner similar to AaxA.  Although both MOMP and AaxA were active under the
conditions tested, MOMP has several conserved cysteine residues that are lacking in
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AaxA and it has been reported that MOMP’s porin activity may be compromised under
oxidizing conditions (Bavoil et al. 1984).  It was therefore possible that AaxA could be
active under conditions where MOMP was not.  Whole cell arginine decarboxylase
assays comparing oxidizing conditions to reducing conditions showed a large decrease in
arginine uptake by MOMP under oxidizing conditions that was not observed for AaxA.
It is not currently known when AaxA is expressed during the chlamydial life cycle but
this difference between the arginine uptake activities of these two chlamydial porins is
and interesting finding.
Liposome swelling assays using AaxA were used to determine the specificity of
AaxA.  It was originally hypothesized that AaxA might be a specific porin only involved
in arginine uptake.  To examine this hypothesis a variety of solutes were tested for uptake
by AaxA including amino acids, polyamines, and sugars.  The results of these
experiments showed that AaxA is a general porin rather than a specific porin and capable
of taking up a wide variety of substrates.  Of the solutes tested, only large solute
molecules (above about MW 260) and solute molecules with a negative charge were
excluded.  In general, positively charged solutes seem to be most favored with arginine
and arginine analogs being the preferred substrates.  As the pH is increased and arginine
loses its positive charge its rate of uptake is also reduced.  Solute uptake by AaxA at low
pH is reduced much more sharply and agrees with whole cell arginine decarboxylase
assays that show reduced or no increase in activity by AaxA at low pH values.  This
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result also explains why AaxA did not enhance acid survival at pH 2.5, since AaxA has
no detectable activity under such acidic conditions.
4.2. EXPERIMENTAL PROCEDURES
4.2.1. Expression, refolding, and purification of AaxA
E. coli strains were grown aerobically at 37°C overnight in LB Miller broth
supplemented with ampicillin (100 µg ml-1) and L-arabinose (0.15% [wt/volume]) for
DEG0156 carrying pBAD/HisA or derivative plasmids and with α-D-lactose (1%
[wt/volume]) for BL21 (DE3) containing the pET-43.1a-derived pDG596 plasmid.
The (His)6-tagged truncated AaxA was expressed from pDG596 in E. coli BL21
(DE3) and refolded from inclusion bodies in vitro following the method of Rutten et al.
2008.  Inclusion bodies were dissolved in 8M urea, 10mM glycine pH 8.3 and AaxA was
refolded by rapid 10-fold dilution into 4% n-dodecyl-β-D-maltoside (DDM) (wt/volume)
20 mM glycine pH 8.3.  The diluted sample was then incubated at 37°C for 18 h and
excess urea was removed by dialysis in 5mM Tris-HCl pH 8 containing 0.1% DDM
(wt/vol).  The refolded AaxA was purified using Ni-NTA agarose affinity
chromatography.  1 ml of packed Ni-NTA agarose was washed 3 times with 5 ml of
deionized water and twice with 5 ml of wash buffer containing 20mM Tris-HCl,  20%
glycerol (vol/vol), 0.05% DDM (wt/vol) pH 8.  Washes were carried out by
centrifugation at 180 g for 1 min using a Beckman Coulter JS-5.3 swinging bucket rotor.
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The Ni-NTA agarose was then equilibrated in wash buffer on ice for 1 h before being
mixed with the refolded AaxA at 4°C for 2 h before being sedimented and washed 10
times in 5 ml wash buffer.  The Ni-NTA agarose was then washed 5 times with 1 ml
elution buffer containing 20 mM Tris-HCl, 200mM imidazol, 10 % glycerol (vol/vol),
and 0.05% DDM (wt/vol) pH 7.5.  Supernatants from the washes with elution buffer were
analyzed by SDS-PAGE.  The eluant was concentrated by centrifugation.
4.2.2. Arginine uptake and decarboxylation assays with whole cells
These assays were performed as described previously (Smith and Graham 2008)
using DEG0156 carrying pBAD/HisA, pDG512 (AaxA), or pDG569 (MOMP).  1mM
dithiothreitol (DTT) was added to reaction mixtures to determine the effects of reducing
conditions on activity.  All reactions were carried out at pH 4.0.
4.2.3.  Liposome swelling assays
Porin function of AaxA using either extracted outer membrane protein from E. coli
DEG0156 carrying pBAD/HisA or pDG512 or the refolded and purified AaxA expressed
from BL21 (DE3) pDG596 was assessed using the liposome swelling assay of Nikaido
and Rosenberg (1983).  Liposomes containing 2.4 µmol of egg phosphatidyl-choline and
0.2 µmol of dicetylphosphate were made by suspending the lipids in chlorform and
drying under nitrogen at 45°C for 3 hours before the film was resuspended in 0.2 ml
aqueous solution containing the porin and sonicated in a bath-type sonicator for 20 min.
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The solution was dried for 2 minutes by rotary evaporation in a water bath at 45°C and
then additionally dried for 2 hours in a desicator over CaSO4.  The proteoliposomes were
resuspended in 0.4 ml 15% dextran (M.W. 35,000-50,000) in 5 mM Tris-HCl, pH7.5.  20
µl of dextran-containing liposomes was diluted into 0.6 ml test solutions containing 5
mM Tris-HCl, pH7.5 with an iso-osmotic concentration of the test solute.  Iso-osmotic
concentrations, the concentrations that caused no net swelling or shrinking of the
liposomes, were determined independently for all substrates using liposomes containing
no porin.  The change in absorbance of the test solution was measured at 400 nm for 3
minutes.  The swelling rates were determined as Δ(1/A)/ Δt from the absorbance changes
between 0 and 30 s.  To test the effect of antibodies on AaxA-mediated liposome
swelling proteoliposomes were incubated with HSV-tag monoclonal antibody or T7-tag
monoclonal antibody (Novagen) for 30 minutes before diluting proteoliposomes into the
test buffer.
Additionally outer membranes were obtained from DEG0156 (pDG512) and
DEG0156 (pBAD/HisA) by sucrose-density gradient centrifugation as previously
described and the washed outer membrane preparations were reconstituted into liposomes
following the above procedure (Smith and Graham, 2008).
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4.3. RESULTS
4.3.1. Expression and localization to the outer membrane
The aaxA gene from C. pneumoniae was fused to a carboxy-terminal HSV tag and
expressed from the plasmid pDG512 in E. coli DEG0147 as well as in E. coli BW25113
with pDG552 and pDG561 and in BL21 (DE3) with pDG552.  The LepA-S-Tag
cytoplasmic marker protein was expressed from pDG561 and the OmpX-S-Tag outer
membrane marker protein was expressed from pDG552.  The cells were grown
aerobically, harvested, lysed, and the membranes were separated by sucrose density
gradient centrifugation as described in the experimental procedures in chapter 3.  The
proteins were separated by SDS-PAGE and analyzed by Western blotting with a
monoclonal HSV antibody.  The cells expressing AaxA-HSV showed a new band with an
apparent molecular mass of 44 kDa (49 kDa calculated).  This band was identified in the
lane corresponding to the outer membrane fraction but was not associated with the
cytoplasmic membrane fraction (Figure 4.1).  Additionally the AaxA band colocalized
with the outer membrane marker OmpX-S-tag, which was detected using a monoclonal
antibody against the S-Peptide (Smith and Graham, 2008).
The outer membrane fraction was washed with 5 M urea to remove protein
expressed in inclusion bodies, which can colocalize with outer membrane proteins.  Only
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very small amounts of epitope-tagged protein were removed by this urea wash,
demonstrating that AaxA is an integral outer membrane protein.  Some of the
heterologously expressed OmpX-S-Tag protein formed insoluble aggregates, which has
been previously reported (Pautsch et al., 1999).  Even so, a significant amount of the
protein incorporated into the outer membrane fraction and was shown to resist removal
by washing with urea (Smith and Graham, 2008).
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Figure 4.1.  AaxA-HSV is localized to the outer membrane
Western blots show the AaxA-HSV protein was expressed in the outer membrane
of E. coli. Lane 1 contains total membrane extract from E. coli BW25113(pBAD/HisA)
control cells. Lane 2 contains the soluble portion of lysate from BL21(DE3)(pDG512,
pDG552) cells expressing C. pneumoniae AaxA-HSV and E. coli OmpX-S-Tag proteins,
after centrifugation for 15 min at 18,000 x g. Lane 3 contains the insoluble portion of the
lysate from BL21(DE3)(pDG512, pDG552) cells. Lane 4 contains the outer membrane
fraction of the same cells, purified by sucrose density-gradient centrifugation and washed
with 5 M urea. Lane 5 contains urea-soluble material from washing the outer membrane
fraction shown in lane 4. Lane 6 contains the cytoplasmic membrane fraction from
sucrose density-gradient centrifugation. Lane 7 contains the pellet from the sucrose
density-gradient centrifugation. (A) The AaxA-HSV protein was detected using an anti-
HSV monoclonal antibody. (B) The OmpX-S-Tag protein was detected using an anti-S-
Tag monoclonal antibody.
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4.3.2. AaxA enhances uptake, DC activity by AdiAC
AaxA was able to significantly enhance arginine uptake and decarboxylation in
whole cell decarboxylase assays using E. coli DEG0147 (pDG484) as described in
chapter 3.  In those assays the AaxB arginine decarboxylase and the AaxC arginine
agmatine antiporter from C. pneumoniae were responsible for the activity and AaxA
presumably enhanced this activity by acting as an outer membrane porin and increasing
the rate at which arginine could enter the cell.  If this is the case, AaxA was predicted to
be able to enhance arginine uptake and decarboxylase activity by the arginine
decarboxylase AdiA and the arginine agmatine antiporter AdiC expressed in wild type E.
coli.  E. coli MG1655 (pDG512) cells were tested for arginine uptake and
decarboxylation along with MG1655 (pBAD/HisA) at pH 2.5, the optimum pH for the E.
coli arginine agmatine exchange system, but there was no significant difference in
activity between the cells expressing AaxA and the control cells.  However, at pH 4, a
compromise between the optimum pH of the E. coli proteins and the heterologously
expressed AaxA, cells expressing AaxA showed a 4-fold increase in activity over the
control strain, a result consistent with what was observed with AaxA in cells expressing
AaxBC instead of AdiAYC (Figure 4.2).   In chapter 2 it was shown that AaxA did not
enhance acid survival at pH 2.5, this additional finding that AaxA cannot enhance
arginine agmatine exchange at pH 2.5 helps explain that result, suggesting that AaxA is
not effective at such low pH (Smith and Graham 2008).
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Figure 4.2.  AaxA enhances whole cell decarboxylase activity in a pH-dependent
fashion.
E. coli MG1655 cells expressing no chlamydial porin (light gray) and AaxA from
pDG512 (dark gray) were assayed for arginine decarboxylase activity at pH 2.5 and pH
4.0. Cells were incubated with [14C]-L-arginine as described previously.  Arginine uptake
and decarboxylation by AdiC and AdiA is enhanced by AaxA at pH 4.0, but not at pH
2.5. Error bars show the standard deviations from the mean of triplicate experiments.
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To further examine the effects of AaxA on arginine uptake in these whole cell
decarboxylase assays an E. coli strain depleted for OmpC and OmpF was constructed to
reduce interference from E. coli porins. The E. coli strain DEG0156 was therefore used to
further assess the activity of heterologously expressed AaxA and to compare it to the
major outer membrane protein (MOMP) from C. pneumoniae.  DEG0156 was
transformed with pBAD/HisA to act as a negative control, pDG512 which expresses
AaxA, or pDG569 which expresses MOMP.  It was observed that in this reduced
background strain both MOMP and AaxA significantly increase arginine uptake and
decarboxylase activity over E. coli carrying pBAD/HisA under the conditions tested
(Figure 4.3).  Compared with the negative control, AaxA increased arginine uptake and
decarboxylation 6-fold while MOMP increased activity 4-fold.  Because of differences in
the expression levels of MOMP and AaxA when heterologously expressed in E. coli, it
cannot be concluded from this result alone that AaxA is more efficient at arginine uptake
than MOMP but in E. coli depleted for OmpC and OmpF it is clear than both chlamydial























Figure 4.3.  AaxA and MOMP enhance whole cell decarboxylase activity
E. coli BW25113 as well as E. coli DEG0156 (ΔompC ΔompF) cells expressing no
chlamydial porin (pBAD/HisA), MOMP (pDG569), and AaxA (pDG512) were assayed
for arginine decarboxylase activity at pH 4.0.  Both MOMP and AaxA demonstrated an
ability to significantly enhance the arginine uptake and decarboxylation activity of E. coli
AdiA and AdiC, effectively rescuing the function lost in DEG0156 by deleting ompC and
ompF.  Error bars show the standard deviations from the mean of triplicate experiments.
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4.3.3. Oxidizing vs. reducing conditions 
While both MOMP and AaxA allow arginine to efficiently cross the outer
membrane it was not clear if both would do so under other conditions than those initially
tested.  It has been demonstrated that MOMP activity can be enhanced in reducing
environments due to a change in the crosslinking of cysteine residues (Bavoil et al.,
1983).  Due to the lack of conserved cysteine residues in AaxA, it was expected that there
should be no significant change in activity when 10 mM DTT was added to reactions.
The results for whole cell decarboxylase assays comparing reducing conditions to
oxidizing conditions showed a 38% enhancement in arginine uptake and decarboxylation
for cells expressing MOMP when under reducing conditions but no significant difference
was observed for cells containing AaxA under the same conditions (Figure 4.4).  These
results were supported by the findings that the addition of DTT had no effect on the






















Figure 4.4.  AaxA porin activity is not significantly inhibited under oxidizing
conditions.
Whole cell arginine decarboxylase assays were performed using DEG0156 to reduce
background activity from OmpC and OmpF.  MOMP was expressed from pDG569,
AaxA was expressed from pDG512, and pBAD/HisA was used as a control. Activity is
given in µmol min-1.  Reaction mixtures were incubated with 10 mM concentrations of
DTT to create reducing conditions or 10 mM iodine to create oxidizing conditions.
Reactions were carried out at pH 4 and were otherwise unchanged from the whole cell
decarboxylase assays described previously.  These results indicate that while MOMP
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from C. pneumoniae is partially inhibited under oxidizing conditions, AaxA is not
significantly affected.  The pBAD/HisA negative control also did not demonstrate a
significant change in arginine uptake by remaining E. coli porins. Error bars show the
standard deviations from the mean of triplicate experiments.
4.3.4. Refolding and purification of AaxA
Active AaxA porin, as determined by the liposome swelling assays described in
the next section, was obtained both from the outer membranes of DEG0156 (pDG512)
obtained by sucrose-density gradient centrifugation and from protein refolded from
inclusion bodies in BL21 (DE3) (pDG596).  Comparisons between OMP-containing
liposomes from DEG0156 (pDG512) and DEG0156 (pBAD/HisA) were used to verify
that liposome swelling in the presence of various substrates was mediated by AaxA and
not E. coli porins such as OmpA.  In spite of the notable difference in the uptake of
different substrates by OM enriched for AaxA as opposed to E. coli OM not expressing
this porin, heat modifiability, a trait of many outer-membrane proteins, was not observed
by gel electrophoresis (Figure 4.5).  The heat-denatured form of AaxA showed the same
electrophoretic mobility as the correctly folded form, which is unusual for outer
membrane porins.  After purification of the refolded AaxA from BL21 (DE3) (pDG596),
heat modifiability was again unobservable using SDS-PAGE and Western blot, although
the liposome swelling activity did contrast significantly with that seen using liposomes
containing the total protein refolded from the inclusion bodies.
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Figure 4.5.  Expression and purification of AaxA-HSV
Samples containing AaxA were mixed with sodium SDS in loading dye and boiled (lanes
3 and 5) or left unboiled (lanes 2 and 4) before separation using SDS PAGE and
coomassie staining (lanes 2 and 3) or immunoblotting with monoclonal antibody against
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4.3.5.  Liposome swelling assays
Refolded AaxA was incorporated into liposomes and swelling rates were
determined using arginine as a solute.  Dextran-containing liposomes were diluted into
test solution containing arginine at iso-osmotic concentration in 5mM Tris-HCl, pH 8,
except when testing a range of pH values.  Modified E-media was used at 1/18 dilution
for pH values of 6 and lower.  The swelling rate was observed by a decrease in refractive
index that causes a decrease in the optical density at 400 nm.
AaxA was added to liposomes at increasing concentrations with arginine as the
test solute to show that porin concentration in the liposomes directly correlates with
swelling rates (Figure 4.6).  The results demonstrated a clear correlation between the
amount of AaxA incorporated into the liposomes and the rate of arginine uptake.  The
results of these assays were used to identify an ideal concentration of AaxA for use in
future assays, which was determined to be 12 ng of protein for each reaction.
Arginine uptake by AaxA was also examined under different pH conditions to
determine the pH dependence of AaxA (Figure 4.7).  Because the previous results with
whole cell decarboxylase assays as well as acid survival assays suggested that AaxA was
not active at pH 2.5, AaxA was expected to have a more moderate pH optimum.
Swelling assays with arginine as the test solute demonstrated that AaxA does not allow
for detectable uptake of arginine below a pH of 3 and the optimum pH for arginine
uptake was between 6 and 8.  Arginine uptake dropped and then remained constant from
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pH 9 to 10, although this is likely caused by the change in the net charge of arginine,
whose amino group has a pK value of 9, rather than a change in the porin itself.  Arginine
should begin to lose its positive charge at pH 9.  If AaxA does have a preference for
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Figure 4.6.  Arginine uptake increases with increasing addition of AaxA porin
Liposome swelling analysis of AaxA refolded from E. coli BL21 (DE3) pDG596
inclusion bodies. AaxA was added at 4 ng (empty circles), 6 ng (empty squares), 8 ng
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Figure 4.7.  Arginine is taken up by AaxA in a pH-dependent manner.
Liposome swelling analysis of AaxA refolded from E. coli BL21 (DE3) pDG596
inclusion bodies was performed at pH values of 3 through 10.  Swelling rates are
calculated as Δ(1/A)/ Δt from the absorbance changes between 0 and 30 s.
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To address the issue of possible contamination of purified AaxA with active
porins from E. coli two methods were used.  First, assays were performed using
liposomes made with porin from unpurified protein extracted from the inclusion bodies
(Figure 4.8) and compared with the activity observed with the purified AaxA (Figure
4.9).  Notably, swelling in the presence of sucrose and glucosamine-6-phosphate, which
was significant in pre-purification samples, was reduced to insignificance with purified
AaxA.  The complete lack of sucrose uptake by the purified AaxA is strong evidence for
the removal of E. coli porins, which should take up sucrose at a significant rate (Jap et al
1996).  Glucose-6-phosphate, which was also taken up at very high rates in pre-
purification samples showed a considerable drop in swelling, although some very limited
swelling did occur.   The second method used to address the purity of AaxA was to
examine inhibition by monoclonal antibodies against the HSV-tag that is present on the
refolded AaxA.  It was observed that swelling rate in liposomes containing purified AaxA
was reduced by greater than 60% in the presence of anti-HSV while antibody against the
T7 antigen used as a negative control showed no significant reduction in activity.  Pre-
purification protein showed a drop in swelling rates with the addition of anti-HSV that
was much less pronounced, roughly 17%, consistent with the presence of E. coli porin
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Figure 4.8.  Inhibition of arginine uptake using monoclonal antibodies with
liposomes made with total protein refolded from inclusion bodies.
Liposome swelling inhibition by monoclonal antibodies in liposomes containing total
protein refolded from inclusion bodies.  Proteoliposomes were inclubated for 30 minutes
at room temperature in the absence of antibody (filled circles), in the presence of HSV-
tag monoclonal antibody (empty squares), and T7-monoclonal antibody (empty
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Figure 4.9. Inhibition of arginine uptake using monoclonal antibodies with
liposomes made with purified AaxA.
Liposome swelling inhibition by monoclonal antibodies in liposomes containing purified
AaxA.  Proteoliposomes were incubated for 30 minutes at room temperature in the
absence of antibody (filled circles), in the presence of HSV-tag monoclonal antibody
(empty squares), and T7-monoclonal antibody (empty diamonds) before the liposome-
swelling assay was performed using arginine as the test solute.
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4.3.6. Sugar substrates and size dependence
The effects of solute size on liposome-swelling rate are most observable with
sugars with the D-ribose taken up most quickly while the larger sucrose and stachyose, a
tetrasccharide consisting of two D-galactose units, one D-glucose unit, and one D-
fructose unit, caused no detectable swelling (Figure 4.10).  When using most of these
solutes, size seems to be the only factor affecting the rate of uptake by AaxA.  This is to
be expected, as size is one of the major factors that determine the ability of solute
molecules to pass through a porin.  However, D-ribose is taken up at a significantly
higher rate than L-arabinose even though both molecules have the same molecular
weight.  While the differing stereochemistry may be a factor in this discrepancy, a more
important factor may be that D-ribose exists more prominently in the furanose form than
L-arabinose and it’s possible that the 5-membered furanose ring can be taken up more
readily than the 6-membered pyranose ring (Angyal and Pickles, 1972). The
physiological relevance of these sugars as substrates for AaxA cannot be determined
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Figure 4.10.  AaxA allows the uptake of sugars in a size-dependent manner
Liposome swelling in isotonic sugar solutions of stachyose (empty squares), sucrose
(empty circles), glucose (filled squares), arabinose (filled circles), and ribose (filled
triangles) shows a clear size-dependence with larger sugars being excluded from uptake
by AaxA.
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4.3.7. Other amino acids and charge dependence
In addition to arginine, many other amino acids were tested as solutes (Table 4.1).
At iso-osmotic conditions it was observed that arginine was taken up most efficiently,
regardless of whether D or L-arginine was used, with other positively charged amino
acids also being good substrates.  Of uncharged solutes, only cysteine was taken up as
efficiently as arginine.  Negatively charged amino acids were the worst substrates,
suggesting that AaxA preferentially takes up positively charged solutes and discriminates
against solutes with a net negative charge.  As with sugars, size also plays a role in the
uptake rates of amino acids by AaxA.
4.3.8. Polyamines
Agmatine and other polyamines were also tested as solutes for AaxA using
liposome-swelling assays (Table 4.1).  As with the sugars, size played the biggest role in
determining uptake efficiency.  Putrescine, having the lowest molecular weight of the
tested polyamines, was taken up most efficiently while spermidine, the largest polyamine
tested, was taken up least efficiently.  Argininamide, one of the larger molecules tested,
was also taken up poorly in spite of having the greatest net positive charge.  Agmatine,
having an intermediate molecular weight, fell in the middle of the pack, making it a good
substrate, but not on par with arginine, its partner in arginine agmatine transport by
AaxC.
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4.3.9. Liposomes made with outer membranes
In addition to the previously described liposome swelling assays made with
refolded AaxA purified from inclusion bodies, AaxA was expressed in the outer
membrane of DEG0156 (pDG512) as before and the outer membrane was isolated by
sucrose-density gradient centrifugation and reconstituted into liposomes.  Outer
membranes from DEG0156 (pBAD/HisA) were used as a control.  The results from these
assays showed a difference in uptake between outer membranes expressing AaxA and
those that did not but there is some discrepancy between these results and those obtained
using refolded and purified AaxA (Table 4.2).  This can likely be attributed to the
difference in relative abundance of E. coli porins and AaxA.  Glutamic acid and aspartic
acid are still very poor substrates and arginine is still taken up much more efficiently than
most other amino acids.  Notably sucrose is taken up at a significantly lower rate in
AaxA-enriched liposomes compared with those containing only E. coli porins.  This not
only confirms that AaxA does not allow the uptake of sucrose, but that E. coli porins do
allow sucrose uptake.  The fact that there is no detectable sucrose uptake in liposomes
made with refolded and purified AaxA therefore indicates that there is no contamination
by E. coli porins contributing to the results observed in those assays.  Oxaloacetate was
tested in this assay, as it is a substrate for the dicarboxylate-specific chlamydial porin,
PorB but it was determined not to be a substrate for AaxA.
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Table 4.1.  Liposome swelling assays using refolded AaxA
Test solute MW Rate (min-1) %G
Glycine 75 0.854 100
Isoleucine 131 0.765 89.6
Alanine 89 0.437 51.1
Methionine 149 0.322 37.8
Valine 117 0.303 35.4
Phenylalanine 165 0.83 97.2
Cysteine 121 0.978 115
Proline 115 0.625 73.2
Serine 105 0.378 44
Asparagine 132 0.356 42
Glutamine 146 0.316 37
Threonine 119 0.24 28
D-Arginine 174 1.012 119
L-Arginine 174 0.992 116
Homoarginine 188 0.863 101
Citrulline 175 0.843 98.7
Lysine 146 0.756 88
Canavanine 177 0.479 56
Histidine 155 0.298 34.9
Putrescine 88 0.945 111
Cadaverine 102 0.819 95.9
Agmatine 130 0.628 73.5
Argininamide 246 0.203 23.8
Spermidine 250 0.168 6.97
Glutamic Acid 147 0.116 13.6
Aspartic Acid 133 0.018 2.1
D-Ribose 150 1.081 126
L-Arabinose 150 0.649 76
Glucose 180 0.538 63
Sucrose 342 0.0179 2.1
Stachyose 667 0.0045 0.5
Oxaloacetate 132 0.441 51.6
Isoketovalerate 132 0.169 19.8
Glucose-6-phosphate 260 0.084 9.8
Glucosamine-6-phosphate 258 0.0111 1.3
Refolded AaxA obtained from DEG0156 (pDG596) was reconstituted into liposomes.
Liposome swelling assays were carried out in test solutions containing iso-osmotic
concentrations of the indicated solute.  Absorbance readings were taken at 400 nm and
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swelling rates were determined as Δ(1/A)/ Δt from the absorbance changes between 0 and
30 s.  All rates were also normalized relative to glycine (%G).
Table 4.2.  Liposome swelling assays using outer membranes
Test solute MW OM + AaxA (%G) OM - AaxA (%G)
Glycine 75 100  (0.579) 100  (0.582)
Alanine 89 151 98
Leucine 131 148 69
Valine 117 129 57
Methionine 149 100 81
Phenylalanine 165 113 85
Serine 115 110 52
Threonine 119 89 50
Cysteine 121 88 42
Asparagine 132 60 86
Glutamine 146 58 52
Arginine 174 137 46
Histidine 155 124 47
Aspartic acid 133 74 65
Glutamic acid 147 65 62
Agmatine 130 26 3
Sucrose 342 27 52
Oxaloacetate 132 38 156
Outer membranes obtained from E. coli DEG0156 were reconstituted into liposomes.
Outer membranes expressing AaxA from pDG512 were compared with control
membranes from cells carrying pBAD/HisA.  Liposome swelling assays were carried out
as before.  Absorbance readings were taken at 400 nm and swelling rates were
determined as Δ(1/A)/ Δt from the absorbance changes between 0 and 30 s and
normalized relative to glycine (%G).  The rate of uptake for glycine was 0.579 min-1 for
outer membranes expressing AaxA and 0.582 min-1 for control membranes without
AaxA.  Oxaloacetate was tested because it is a substrate for PorB but it does not appear to
be taken up by AaxA.
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4.4.  DISCUSSION
It was demonstrated in chapter 3 that AaxA enhances in vitro arginine uptake and
decarboxylation as part of the AaxABC arginine-agmatine exchange system (Smith and
Graham 2008).  In this section the porin activity of AaxA was investigated using a wide
assortment of substrates in addition to arginine and agmatine.  While arginine is taken up
more efficiently than other amino acids tested in this study, AaxA does seem to have a
broader specificity than we originally hypothesized.  Sugars seem to diffuse through the
AaxA porin in a size-dependant manner with D-ribose resulting in the highest rate of
liposome swelling while sucrose seems to be unable to diffuse through the porin at a
detectable rate.  This shows a marked contrast with E. coli porins such as OmpF, OmpC,
and OmpA, which all have an approximate exclusion limit of 600 Da and therefore would
be expected to allow some uptake of sucrose, which has a molecular weight of 342 Da
(Jap et al 1996).  The uptake of sucrose by E. coli porins was confirmed here in
liposome-swelling assays using outer membrane preparations.  It was shown that sucrose
uptake was significantly lower in liposomes containing outer membrane protein enriched
for AaxA than in those containing only E. coli outer membrane proteins.  The inability of
sucrose to cause swelling in liposomes made with refolded and purified AaxA is
therefore a good indicator that the liposomes are not contaminated with E. coli porins.
Arginine diffuses through the AaxA porin very efficiently compared with other
solutes, which seems to be attributable in part to its positively charged side chain.
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Histidine and canavanine, which have lower pKa values for their side chains, have a
neutral charge at the pH used for the liposome swelling assays and also had a much lower
rate of uptake.  Lysine, homoarginine, and citrulline, which have positively charged side
chains under the tested conditions were taken up much more efficiently.  It is worth
noting that argininamide, an inhibitor of AaxB (Giles and Graham 2007), which has a
higher net charge than arginine did not diffuse as efficiently through the AaxA porin as
other positively charged molecules that were tested, most likely due to its larger size.
Amino acids with negatively charged side chains were the worst of the solutes tested for
diffusion through the AaxA porin.  In general, uncharged polar and non-polar amino
acids were not taken up as efficiently as the amino acids with positively charged side
chains, although glycine was able to diffuse very efficiently through the porin, possibly
because of its relatively small size.  Isoleucine, cysteine, and proline were also taken up
efficiently.  Among polyamines tested, diffusion efficiency seemed size-dependant as
was observed for the tested sugars.
C. pneumoniae AaxA has 2 cysteine residues located at position 69 and position
292 but these are not conserved in other Chlamydia species.  Reducing conditions created
using DTT had no significant affect on swelling rates in liposomes containing purified
AaxA, suggesting the possibility that AaxA may be active in vivo under oxidizing
conditions where chlamydial MOMP’s conserved cysteine residues would form
inactivating intramolecular disulfide bonds (Bavoil et al. 1984).  Decarboxylase assays
using whole E. coli cells under reducing conditions showed no significant change in
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uptake for cells expressing AaxA while under the same conditions cells expressing
MOMP showed a 38% enhancement of activity, suggesting a partial inactivation under
oxidizing conditions that is not observed for AaxA.
Liposome swelling assays showed that arginine uptake through AaxA is highest at
pH 6-8, dropping and leveling off at pH 9.  The amino group of arginine has a pK value
of 9, and the loss of positive charge at this pH is likely the cause of the reduction in
uptake by AaxA at pH 9 and above. As the pH drops below 6, arginine uptake decreases
markedly, approaching insignificance bellow pH 3.  This relatively high optimal pH
explains why AaxA had no significant impact on acid survival in E. coli AdiAYC mutants
at pH 2.5 as reported previously (Smith and Graham 2008).  This result suggests that
AaxA may undergo a conformational change under acidic conditions as has been
observed for E. coli OmpF and OmpC (Todt et al. 1992).  Additional structural data and
mutation experiments will be beneficial to determine the mechanics of AaxA’s pH-
sensitivity.
AaxA has been observed in this study to be a general porin with a preference for
positively charged solutes.  All tested solutes with a molecular weight less than that of
sucrose showed efficient uptake with the exception of solutes with a net negative charge,
which seem to be discriminated against by AaxA.  It is worth noting that while aspartate
and glutamate are not taken up at significant rates by AaxA, MOMP has been
demonstrated to efficiently transport these amino acids (Jones et al. 2000).  The largest
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solute molecule tested that showed a significant rate of uptake was spermidine (MW
250).  It was demonstrated in this study by whole cell decarboxylase assays using E. coli
expressing AaxA and MOMP that both porins can enhance arginine uptake and while the
question of whether they both do so under the same conditions in vivo has yet to be
answered it does seem that the two porins may partially complement each other in their
preferences for different amino acid substrates.
We hypothesized previously that the AaxABC arginine agmatine exchange system
may have a role in virulence by consuming host arginine, the substrate for inducible nitric
oxide synthase (iNOS), and thereby targeting the innate immune response (Smith and
Graham 2008).  While AaxA’s role in such a system remains a possibility worthy of
future investigation, it may also be important as a general porin involved in the uptake of
a wide assortment of biomolecules required by Chlamydia for survival.
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CHAPTER 5
Summary and future directions
5.1 SUMMARY
This study focuses on the discovery of two membrane proteins from Chlamydia
pneumoniae, the inner membrane arginine-agmatine antiporter AaxC and the outer
membrane general porin AaxA.  In the first section it was determined that AaxC is
localized to the cytoplasmic membrane when heterologously expressed in E. coli and that
it is able to transport arginine into the cell.  Arginine uptake by AaxC was most efficient
between pH 5 and 6.  Although C. pneumoniae is not able to synthesize its own arginine,
it does have an operon regulated by the ArgR repressor that encodes a putative ABC-type
arginine transporter.  This suggests that AaxC should not be required for protein synthesis
and must therefore serve another role.
Arginine uptake and degradation systems serve many different roles in bacteria and
archaea ranging from ATP production to polyamine biosynthesis.  However C.
pneumoniae lacks the arginine deiminase gene required for producing ATP from arginine
fermentation as well as the agmatine ureohydrolase required to convert agmatine to
putrescine.
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AaxB, the arginine decarboxylase from C. pneumoniae can decarboxylate arginine
imported by AaxC to produce agmatine, but this reaction must serve a purpose other than
polyamine biosynthesis.  In E. coli a system coupling the arginine decarboxylase AdiA
with the arginine-agmatine antiporter AdiC is one of several systems for amino acid
uptake and decarboxylation used to allow these bacteria to survive the low pH
environment of the stomach prior to colonizing the gut.  In these systems amino acid
decarboxylation uses up protons while creating an internal positive charge to repel
protons and maintain an elevated pH inside the cell.
In spite of the fact that C. pneumoniae is not expected to encounter an extremely low
pH environment during its life cycle it was found that coexpression of AaxB and AaxC in
E. coli adiAYC mutants subjected to acid shock in the presence of arginine can rescue
survival.  This survival was comparable to wild type levels and was fully dependent on
the presence of arginine in the acid shock medium.  This result suggests that AaxC
functions in the same way as the arginine-agmatine antiporter AdiC.  The AaxA porin
was unable to enhance survival due to its being inactive at pH 2.5.
To investigate AaxC in more detail the same E. coli adiAYC mutants expressing the
aax genes were used to verify that agmatine was exported by AaxC using strong cation
exchange HPLC to separate radiolabeled reaction products for analysis by liquid
scintillation counting.  Arginine-agmatine exchange by AaxBC was observed under the
conditions used for acid shock in the previously mentioned complementation assays but
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much greater conversion was observed at pH 5, the optimum pH for arginine uptake by
AaxC alone.  Whole cell decarboxylase assays verified that arginine-agmatine exchange
by AaxBC was most efficient between pH 3 and 5, an apparent compromise between the
higher pH optimum of AaxC and that of AaxB, which is most efficient at pH 3.4.
The second portion of this study focused on the C. pneumoniae porin AaxA.
Although AaxA could not enhance acid survival by AaxBC, whole cell decarboxylase
assays showed that it could significantly enhance arginine uptake and therefore
decarboxylation in whole cells incubated at pH 3 and above.  This enhanced uptake was
most apparent from pH 3 to 6.  Enhanced uptake at pH 7 and above was not detectable
with this assay because AaxB is not active under these conditions.
AaxA was also able to enhance arginine uptake and decarboxylation by AdiA and
AdiC in wild type E. coli as well as E. coli mutants defective for the native E. coli porins
OmpC and OmpF.  This result was not observed at pH 2.5 but was very clear at pH 4.
Unlike C. pneumoniae MOMP, the most studied chlamydial porin, AaxA was fully
functional under oxidizing conditions when MOMP is partially inactivated by the
formation of disulfide bonds.  This suggests the possibility that although AaxA and
MOMP both facilitate arginine uptake, AaxA may be able to do so under conditions
when MOMP cannot.
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AaxA is a general porin and liposome swelling assays showed that in addition to
arginine and agmatine, AaxA allows for the uptake of a wide variety of amino acids,
polyamines, and sugars.  Large molecules (> MW 260) as well as molecules with a net
negative charge seem to be excluded while positively charged solute molecules, in
general, are taken up most efficiently.  It is noteworthy that with increasing pH, arginine
is taken up very efficiently until pH 9 when it starts to lose its net positive charge.  Above
pH 9, the rate of arginine uptake drops and then levels off.  Uptake of arginine is most
efficient between pH 6 and 8 with a rapid drop bellow pH 6.  Confirming results obtained
in acid resistance and decarboxylase assays, AaxA is not active bellow pH 3.
The results obtained in this study show that AaxA and AaxC can act together with
AaxB as a system for arginine-agmatine exchange.  However, the broad specificity of
AaxA suggests that it may have a role in chlamydial biology that goes beyond this one
system.  Together with MOMP, AaxA may play a major role in importing the various
biomolecules that C. pneumoniae needs to survive during its parasitic life cycle.
The importance of arginine-agmatine exchange to C. pneumoniae has not yet been
determined but there are two distinct possibilities.  Because AaxB and AaxC have been
shown to enhance E. coli survival under conditions of extreme pH, these proteins may
play a role in maintaining pH homeostais in chlamydia.  However, the environment
inside the intracellular inclusion where C. pneumoniae grows is expected to have a
neutral pH as fusion with acidifying lysosomes is believed to be blocked.  Additionally,
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C. pneumoniae should not encounter pH extremes not encountered by C. trachomatis, in
which mutations have inactivated AaxB and with it the organism’s system for arginine-
agmatine exchange.  The relaxed selection for the maintenance of AaxB in C.
trachomatis but not in C. pneumoniae suggests that differences in tissue tropism may lead
to different pressures affecting this system.  C. pneumoniae, unlike C. trachomatis, is
expected to encounter nitric oxide as part of the hosts innate immune system while
infecting alveolar macrophages.  Inducible nitric oxide synthase (iNOS) uses arginine as
a substrate to produce nitric oxide and expression of iNOS is regulated by arginine
abundance.  If C. pneumoniae uses AaxB and AaxC to deplete host cell arginine in the
same way as Helicobacter pylori with its arginine deiminase then this difference between
these chlamydial species could be explained.  Additionally agmatine may be converted
by the host enzyme diamine oxidase to 4-guanidinobutyraldehyde, a potent inhibitor of
iNOS.  AaxABC may therefore be a virulence factor involved in countering the
production of nitric oxide by the host.
5.2 FUTURE STUDIES
Although AaxC and AaxA have now been characterized in vitro and with the aid of a
heterologous expression system their function in vivo has yet to be explored.  It would be
expected that the aax genes are co-transcribed to facilitate their cooperative action in
arginine-agmatine exchange.  Therefore, it must be verified that aaxABC is transcribed as
a polycistronic mRNA in C. pneumoniae and it must be determined when these genes are
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expressed.  To this end, reverse transcriptase PCR analysis should be performed using
mRNA extracted from cells harvested at different times post-infection.  Polyclonal
antibodies against AaxC and AaxA would be helpful in identifying these proteins in the
cell extract from cells infected with C. pneumoniae using immunoblotting experiments.
Together with RT PCR data these experiments would indicate the stages of the
chlamydial life cycle when these proteins may be required.
Once the expression of the aax genes is determined, C. pneumoniae reticulate
bodies or elementary bodies can be harvested under conditions where the Aax proteins
can be expected to be active and subjected to the same whole cell decarboxylase assays
used for E. coli expressing these genes.  These assays would be able to show if these
proteins are active in vivo and would be an important step in determining their
significance to C. pneumoniae.
If C. pneumoniae uses the Aax proteins as a system for inhibiting host iNOS
activity during infection, infection studies using macrophages capable of expressing
iNOS would be essential to verify this role.  Assays for the production of nitric oxide
have been carried out using C. pneumoniae and it was determined that nitric oxide is able
to inhibit C. pneumoniae infection (Carratelli et al., 2005).  However these assays were
carried out in the presence of arginine concentrations 10 times greater than concentrations
found in the lung so it remains to be seen if C. pneumoniae expressing aaxABC is able to
resist inhibition of growth by nitric oxide.
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This dissertation highlights the two new chlamydial membrane proteins AaxC and
AaxA and attempts to show how they may be important to the life cycle of the obligate
intracellular parasite and human pathogen C. pneumoniae.  Although their functions have
been determined in vitro it will take in vivo studies to fully assess their role in the
chlamydial life cycle.
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Appendix: List of microorganisms and plasmids
Strain or Plasmid Description and partial
genotype
Source or reference
E. coli DEG0147 MG1655 ΔAdiAYC::kan Smith and Graham, 2008
E. coli BW25113 ΔaraBADAH33 Datsenko and Wanner, 2000
E. coli JW0912-1 BW25113 ΔompF Baba et al., 2006
E. coli JW2203-1 BW25113 ΔompC Baba et al., 2006
E. coli DEG0156 BW25113 ΔompFΔompC Smith and Graham, pending
publication
pBAD/HisA Expression vector, bla araC Invitrogen
pDG339 aaxB in pBAD/HisA Smith and Graham, 2008
pDG366 aaxBC-HSV in pBAD/HisA Smith and Graham, 2008
pDG379 aaxBC in pBAD/HisA Smith and Graham, 2008
pDG484 aaxABC in pBAD/HisA Smith and Graham, 2008
pDG512 aaxA-HSV in pBAD/HisA Smith and Graham, 2008
pDG552 ompX in pCOLADuet Smith and Graham, 2008
pDG561 lepA in pCDFDuet-1 Smith and Graham, 2008
PDG569 CpnMOMP in pBAD/HisA Smith and Graham, pending
publication
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